<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
 xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:owl="http://www.w3.org/2002/07/owl#"
 xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"
 xml:base="http://www.reactome.org/biopax/91/109582#">
<owl:Ontology rdf:about="">
 <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level3.owl#" />
</owl:Ontology>

<bp:Evidence rdf:ID="Evidence109">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence105">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence348">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence115">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence112">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence354">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence113">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence110">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence352">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence111">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence350">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence351">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis94">
 <bp:controlled rdf:resource="#BiochemicalReaction330" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis93">
 <bp:controlled rdf:resource="#BiochemicalReaction328" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis96">
 <bp:controlled rdf:resource="#BiochemicalReaction335" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis95">
 <bp:controlled rdf:resource="#BiochemicalReaction333" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis98">
 <bp:controlled rdf:resource="#BiochemicalReaction339" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis97">
 <bp:controlled rdf:resource="#BiochemicalReaction337" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis99">
 <bp:controlled rdf:resource="#BiochemicalReaction341" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence337">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence104">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence102">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence100">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence340">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis83">
 <bp:controlled rdf:resource="#BiochemicalReaction295" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis82">
 <bp:controlled rdf:resource="#BiochemicalReaction294" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis85">
 <bp:controlled rdf:resource="#BiochemicalReaction303" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis84">
 <bp:controlled rdf:resource="#BiochemicalReaction300" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis87">
 <bp:controlled rdf:resource="#BiochemicalReaction308" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis86">
 <bp:controlled rdf:resource="#BiochemicalReaction305" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis89">
 <bp:controlled rdf:resource="#BiochemicalReaction316" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis88">
 <bp:controlled rdf:resource="#BiochemicalReaction311" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence329">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence327">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence325">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence326">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence332">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence331">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis90">
 <bp:controlled rdf:resource="#BiochemicalReaction318" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis92">
 <bp:controlled rdf:resource="#BiochemicalReaction322" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis91">
 <bp:controlled rdf:resource="#BiochemicalReaction319" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis72">
 <bp:controlled rdf:resource="#BiochemicalReaction212" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis71">
 <bp:controlled rdf:resource="#BiochemicalReaction211" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis74">
 <bp:controlled rdf:resource="#BiochemicalReaction217" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis73">
 <bp:controlled rdf:resource="#BiochemicalReaction215" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis76">
 <bp:controlled rdf:resource="#BiochemicalReaction265" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis75">
 <bp:controlled rdf:resource="#BiochemicalReaction222" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis78">
 <bp:controlled rdf:resource="#BiochemicalReaction274" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis77">
 <bp:controlled rdf:resource="#BiochemicalReaction268" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis79">
 <bp:controlled rdf:resource="#BiochemicalReaction281" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence318">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence319">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence316">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence317">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence314">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence315">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence324">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence321">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence320">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis81">
 <bp:controlled rdf:resource="#BiochemicalReaction293" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis80">
 <bp:controlled rdf:resource="#BiochemicalReaction291" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction279">
 <bp:evidence rdf:resource="#Evidence314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and Grb7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence309">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence305">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence312">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction270">
 <bp:evidence rdf:resource="#Evidence305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of SOS-1 to Tie2 bound  Grb2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence313">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence310">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence311">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction277">
 <bp:evidence rdf:resource="#Evidence312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and Shp2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction278">
 <bp:evidence rdf:resource="#Evidence313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 with Ang1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction275">
 <bp:evidence rdf:resource="#Evidence310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and Dok-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction276">
 <bp:evidence rdf:resource="#Evidence311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and Grb14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction273">
 <bp:evidence rdf:resource="#Evidence308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and Ang4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction274">
 <bp:evidence rdf:resource="#Evidence309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trans-phosphorylation of Tie2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction271">
 <bp:evidence rdf:resource="#Evidence306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and p85 of PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction272">
 <bp:evidence rdf:resource="#Evidence307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 with Ang2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence301">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction280">
 <bp:evidence rdf:resource="#Evidence315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and Grb2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence302">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction281">
 <bp:evidence rdf:resource="#Evidence316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sos-mediated nucleotide exchange of Ras (Tie2 receptor:Grb2:Sos)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence300">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction288">
 <bp:evidence rdf:resource="#Evidence325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">tissue factor (TF) + activated factor VII (F7a) -&gt; TF:F7a complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction289">
 <bp:evidence rdf:resource="#Evidence326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">tissue factor (TF) + factor VII (F7) -&gt; TF:F7 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction286">
 <bp:evidence rdf:resource="#Evidence321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OLR1 binds to oxidized LDL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction287">
 <bp:evidence rdf:resource="#Evidence322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCAMR binds IgA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction284">
 <bp:evidence rdf:resource="#Evidence319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXADR binds to AMICA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction285">
 <bp:evidence rdf:resource="#Evidence320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CEACAM1,3,5,6 bind opa proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction282">
 <bp:evidence rdf:resource="#Evidence317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of Tie2/Ang1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction283">
 <bp:evidence rdf:resource="#Evidence318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD74 binds MIF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction291">
 <bp:evidence rdf:resource="#Evidence328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor X -&gt; factor Xa + factor X activation peptide (TF:F7 catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction292">
 <bp:evidence rdf:resource="#Evidence329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">sequestered tissue factor -&gt; tissue factor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction290">
 <bp:evidence rdf:resource="#Evidence327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFPI + TF:F7a + factor Xa -&gt; TFPI:TF:F7a:factor Xa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction299">
 <bp:evidence rdf:resource="#Evidence337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor VIIIa + factor IXa -&gt; factor VIIIa:factor IXa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction297">
 <bp:evidence rdf:resource="#Evidence335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor XI + platelet glycoprotein (GP) Ib:IX:V complex -&gt; factor XI:platelet glycoprotein (GP) Ib:IX:V complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction298">
 <bp:evidence rdf:resource="#Evidence336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor VIII + von Willebrand factor multimer -&gt; factor VIII:von Willibrand factor multimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction295">
 <bp:evidence rdf:resource="#Evidence332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor X -&gt; factor Xa + factor X activation peptide (TF:F7a catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction296">
 <bp:evidence rdf:resource="#Evidence334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FIX is secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction293">
 <bp:evidence rdf:resource="#Evidence330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor IX -&gt; factor IXa + factor IX activation peptide (TF:F7a catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction294">
 <bp:evidence rdf:resource="#Evidence331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor VII -&gt; factor VIIa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction239">
 <bp:evidence rdf:resource="#Evidence271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Heterodimerization of CEACAMs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction237">
 <bp:evidence rdf:resource="#Evidence269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alphaLbeta2 (LFA-1) binds F11R (JAM-A)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction238">
 <bp:evidence rdf:resource="#Evidence270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glycophorins bind plasmodium falciparum Ags</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction235">
 <bp:evidence rdf:resource="#Evidence267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD58 binds CD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction236">
 <bp:evidence rdf:resource="#Evidence268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD84 homodimerises</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence197">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence194">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction233">
 <bp:evidence rdf:resource="#Evidence265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAM2 dimerises</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence195">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction234">
 <bp:evidence rdf:resource="#Evidence266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet-derived TREM-1 ligand binds to TREM-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence192">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction231">
 <bp:evidence rdf:resource="#Evidence263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alphaXbeta2 binds JAM3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence193">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction232">
 <bp:evidence rdf:resource="#Evidence264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MERTK receptor binds ligands (Gas6 or Protein S)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence8">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence190">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence9">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence191">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction230">
 <bp:evidence rdf:resource="#Evidence262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alpha4beta1 binds JAM2:JAM3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence6">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence7">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence4">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence5">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction248">
 <bp:evidence rdf:resource="#Evidence280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAM3 dimerises</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction249">
 <bp:evidence rdf:resource="#Evidence282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin binds CD98 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction246">
 <bp:evidence rdf:resource="#Evidence278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E-selectin binds E-selectin ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction247">
 <bp:evidence rdf:resource="#Evidence279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P-selectin binds P-selectin ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence189">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence186">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence183">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction244">
 <bp:evidence rdf:resource="#Evidence276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alphaMbeta2 (MAC1) binds JAM3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence184">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction245">
 <bp:evidence rdf:resource="#Evidence277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">F11R dimerises</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence181">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction242">
 <bp:evidence rdf:resource="#Evidence274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD48 binds CD244</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence182">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction243">
 <bp:evidence rdf:resource="#Evidence275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAM2 binds JAM3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction240">
 <bp:evidence rdf:resource="#Evidence272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD99 binds CD99L2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence180">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction241">
 <bp:evidence rdf:resource="#Evidence273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alpha5beta1 binds FN1 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction259">
 <bp:evidence rdf:resource="#Evidence293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trans-homophilic interaction of PECAM-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction257">
 <bp:evidence rdf:resource="#Evidence290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin interacts with CD43</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction258">
 <bp:evidence rdf:resource="#Evidence291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BSG (basigin) binds Integrin alpha3beta1, alpha6beta1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence179">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence172">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction255">
 <bp:evidence rdf:resource="#Evidence288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin binds CyPA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence173">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction256">
 <bp:evidence rdf:resource="#Evidence289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caveolin-1 binds Basigin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence170">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction253">
 <bp:evidence rdf:resource="#Evidence286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin binds Mannose-carrying cell recognition molecules</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence171">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction254">
 <bp:evidence rdf:resource="#Evidence287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CyP60 chaperones Basigin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction251">
 <bp:evidence rdf:resource="#Evidence284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin homodimerises</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction252">
 <bp:evidence rdf:resource="#Evidence285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin binds Matrix metalloproteinase-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction250">
 <bp:evidence rdf:resource="#Evidence283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin binds MCT1, MCT3 and MCT4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction268">
 <bp:evidence rdf:resource="#Evidence302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated thrombin:thrombomodulin cleaves PROCR:Protein C to PROCR:Activated protein C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction269">
 <bp:evidence rdf:resource="#Evidence304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Tie2 and Shc1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence161">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction266">
 <bp:evidence rdf:resource="#Evidence300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITGA4:ITGB1 binds natalizumab</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence162">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction267">
 <bp:evidence rdf:resource="#Evidence301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPCAM binds itself to form homotypic cell adhesion</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction264">
 <bp:evidence rdf:resource="#Evidence298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PECAM-1 and SHIP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence160">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction265">
 <bp:evidence rdf:resource="#Evidence299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PECAM-1 by Fyn or Lyn or c-Src</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction262">
 <bp:evidence rdf:resource="#Evidence296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PECAM-1 and SHP-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction263">
 <bp:evidence rdf:resource="#Evidence297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of integrin alphaVbeta3 with PECAM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction260">
 <bp:evidence rdf:resource="#Evidence294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PECAM-1 and PLC gamma1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction261">
 <bp:evidence rdf:resource="#Evidence295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PECAM-1 and SHP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence149">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence157">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence154">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence151">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction208">
 <bp:evidence rdf:resource="#Evidence238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PECAM1 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction209">
 <bp:evidence rdf:resource="#Evidence239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGR binds LDL:LRP8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction206">
 <bp:evidence rdf:resource="#Evidence235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP2B1-4 transport cytosolic Ca2+ to extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction207">
 <bp:evidence rdf:resource="#Evidence237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LDL binds to LRP8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction204">
 <bp:evidence rdf:resource="#Evidence233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC8A1,2,3 exchange 3Na+ for Ca2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction205">
 <bp:evidence rdf:resource="#Evidence234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP2A1-3 transport cytosolic Ca2+ to dense tubular network lumen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction202">
 <bp:evidence rdf:resource="#Evidence230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cation influx mediated by TRPC3/6/7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction203">
 <bp:evidence rdf:resource="#Evidence231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRAC translocates calcium from the extracellular region to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence138">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence139">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence387">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence384">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction200">
 <bp:evidence rdf:resource="#Evidence228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R tetramer:I(1,4,5)P3:4xCa2+ transports Ca2+ from platelet dense tubular system to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence381">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence140">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction201">
 <bp:evidence rdf:resource="#Evidence229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STIM1 activation of CRAC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence380">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction219">
 <bp:evidence rdf:resource="#Evidence250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTGIR binds PTGIR agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep280">
 <bp:stepProcess rdf:resource="#Pathway33" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction217">
 <bp:evidence rdf:resource="#Evidence248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gs activation by prostacyclin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction218">
 <bp:evidence rdf:resource="#Evidence249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP receptor can bind prostacyclin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction215">
 <bp:evidence rdf:resource="#Evidence245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fgr may phosphorylate p38 MAPK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction252" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction216">
 <bp:evidence rdf:resource="#Evidence247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of the Prostacyclin receptor:Gs complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction251" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction213">
 <bp:evidence rdf:resource="#Evidence243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PECAM-1 and SHP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction250" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction214">
 <bp:evidence rdf:resource="#Evidence244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PECAM-1 and SHP-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep288">
 <bp:stepProcess rdf:resource="#BiochemicalReaction256" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction255" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction254" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep285">
 <bp:stepProcess rdf:resource="#BiochemicalReaction253" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence129">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence127">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence369">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence128">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction257" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence379">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence376">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence377">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence132">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence130">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence373">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction211">
 <bp:evidence rdf:resource="#Evidence241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of cPLA2 by MAPK p38 alpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence370">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction212">
 <bp:evidence rdf:resource="#Evidence242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGR binds and phosphorylates LRP8</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence371">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction210">
 <bp:evidence rdf:resource="#Evidence240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PECAM-1 binds PP2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep291">
 <bp:stepProcess rdf:resource="#Pathway34" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction258" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction228">
 <bp:evidence rdf:resource="#Evidence260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD177 binds PECAM-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction229">
 <bp:evidence rdf:resource="#Evidence261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of GPVI:Fc Epsilon R1 gamma receptor complex with collagen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction226">
 <bp:evidence rdf:resource="#Evidence258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PSGs bind proteoglycans and TGF-beta1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep295">
 <bp:stepProcess rdf:resource="#BiochemicalReaction262" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction227">
 <bp:evidence rdf:resource="#Evidence259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD47 binds SIRP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction261" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction224">
 <bp:evidence rdf:resource="#Evidence256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SL (surrogate light chain) binds IgH to form pre-BCR</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction260" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction225">
 <bp:evidence rdf:resource="#Evidence257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAIL receptor-4 binds TRAIL receptor-1 or TRAIL receptor-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction266" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep298">
 <bp:stepProcess rdf:resource="#Catalysis76" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction265" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction264" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep296">
 <bp:stepProcess rdf:resource="#BiochemicalReaction263" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence118">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence116">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence358">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence117">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence359">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence368">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence123">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence121">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence361">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence120">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence362">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction222">
 <bp:evidence rdf:resource="#Evidence253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAFAH2 hydrolyses PAF to lyso-PAF and acetate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction223">
 <bp:evidence rdf:resource="#Evidence255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TSPAN7 binds PICK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence360">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction220">
 <bp:evidence rdf:resource="#Evidence251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated prostacyclin receptor binds G-protein Gs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction221">
 <bp:evidence rdf:resource="#Evidence252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of ATP to P2X receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep261">
 <bp:stepProcess rdf:resource="#BiochemicalReaction230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep260">
 <bp:stepProcess rdf:resource="#BiochemicalReaction229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep266">
 <bp:stepProcess rdf:resource="#BiochemicalReaction235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep264">
 <bp:stepProcess rdf:resource="#BiochemicalReaction233" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction238" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2">
 <bp:stepProcess rdf:resource="#Catalysis1" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1">
 <bp:stepProcess rdf:resource="#Pathway2" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep6">
 <bp:stepProcess rdf:resource="#BiochemicalReaction5" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep5">
 <bp:stepProcess rdf:resource="#BiochemicalReaction4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep4">
 <bp:stepProcess rdf:resource="#BiochemicalReaction3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep273">
 <bp:stepProcess rdf:resource="#BiochemicalReaction242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep271">
 <bp:stepProcess rdf:resource="#BiochemicalReaction240" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep277">
 <bp:stepProcess rdf:resource="#BiochemicalReaction246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep9">
 <bp:stepProcess rdf:resource="#BiochemicalReaction8" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep8">
 <bp:stepProcess rdf:resource="#Catalysis3" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction244" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep7">
 <bp:stepProcess rdf:resource="#Catalysis2" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep279">
 <bp:stepProcess rdf:resource="#BiochemicalReaction248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep278">
 <bp:stepProcess rdf:resource="#BiochemicalReaction247" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep240">
 <bp:stepProcess rdf:resource="#Catalysis71" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction211" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep244">
 <bp:stepProcess rdf:resource="#Catalysis73" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction213" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis102">
 <bp:controlled rdf:resource="#BiochemicalReaction347" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep241">
 <bp:stepProcess rdf:resource="#Catalysis72" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction212" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis101">
 <bp:controlled rdf:resource="#BiochemicalReaction344" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction218" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis100">
 <bp:controlled rdf:resource="#BiochemicalReaction342" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction217" />
 <bp:stepProcess rdf:resource="#Catalysis74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep246">
 <bp:stepProcess rdf:resource="#BiochemicalReaction216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep245">
 <bp:stepProcess rdf:resource="#Pathway31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction209" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction307">
 <bp:evidence rdf:resource="#Evidence345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">kininogen + C1q binding protein tetramer -&gt; kininogen:C1q binding protein tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction308">
 <bp:evidence rdf:resource="#Evidence346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor XI:platelet glycoprotein (GP) Ib:IX:V complex -&gt; factor XIa:platelet glycoprotein (GP) Ib:IX:V complex (thrombin catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction305">
 <bp:evidence rdf:resource="#Evidence343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor XII -&gt; factor XIIa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction306">
 <bp:evidence rdf:resource="#Evidence344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor VIIIa dissociates </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction221" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction303">
 <bp:evidence rdf:resource="#Evidence341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">prekallikrein:kininogen:C1q binding protein tetramer -&gt; kallikrein:kininogen:C1q binding protein tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction220" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction304">
 <bp:evidence rdf:resource="#Evidence342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FVIII is secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction301">
 <bp:evidence rdf:resource="#Evidence339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">kallikrein + alpha2-macroglobulin -&gt; kallikrein:alpha2-macrogloulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction302">
 <bp:evidence rdf:resource="#Evidence340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">prekallikrein + kininogen:C1q binding protein tetramer -&gt; prekallikrein:kininogen:C1q binding protein tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep255">
 <bp:stepProcess rdf:resource="#BiochemicalReaction224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep254">
 <bp:stepProcess rdf:resource="#BiochemicalReaction223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep253">
 <bp:stepProcess rdf:resource="#Pathway32" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep252">
 <bp:stepProcess rdf:resource="#Catalysis75" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction222" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep259">
 <bp:stepProcess rdf:resource="#BiochemicalReaction228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep257">
 <bp:stepProcess rdf:resource="#BiochemicalReaction226" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction309">
 <bp:evidence rdf:resource="#Evidence347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor IIa inhibitors (peptide) binds IIa</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction225" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction219" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction300">
 <bp:evidence rdf:resource="#Evidence338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">kallikrein:kininogen:C1q binding protein tetramer -&gt; kallikrein + activated kininogen:C1q binding protein tetramer + bradykinin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction197" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway37">
 <bp:pathwayOrder rdf:resource="#PathwayStep329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep331" />
 <bp:pathwayOrder rdf:resource="#PathwayStep330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction291" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction294" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Extrinsic Pathway of Fibrin Clot Formation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor VII, the protease that initiates the normal blood clotting cascade, circulates in the blood in both its proenzyme (factor VII) and its activated (factor VIIa) forms.  No clotting occurs, however, because neither form of the protein has any catalytic activity when free in solution. Blood clotting is normally initiated when tissue factor (TF), an intrinsic plasma membrane protein, is exposed to the blood by injury to the wall of a blood vessel. TF is then able to bind factor VIIa from plasma, and possibly also factor VII, to form complexes capable of catalyzing the conversion of factor X, from plasma, into its activated form, factor Xa. Factor Xa catalyzes the conversion of additional factor VII molecules to their activated form, increasing the amount of tissue factor:factor VIIa complex available at the site of injury, accelerating the generation of factor Xa, and allowing the activation of factor IXa as well. This process is self-limiting because as levels of factor Xa increase, tissue factor:factor VIIa complexes become trapped in the form of catalytically inactive heterotetramers with factor Xa and the protein TFPI (tissue pathway factor inhibitor). At this point the intinsic pathway, as an independent source of activated factor X, is thought to become critical for the continuation of clot formation (Broze 1995; Mann et al. 2003). The nature of the initial tissue factor:factor VII complexes formed is controversial. One model, building on the observation that the complex of factor VII and TF has low but measurable proteolytic activity on factor X, suggests that this complex begins the activation of factor X, and that as factor VIIa accumulates, tissue factor:factor VIIa complexes also form, accelerating the process (Nemerson 1988).  A second model, building on the observation that normal plasma contains low levels of activated factor VII constitutively, suggests that complexes with factor VIIa form immediately at the onset of clotting (Rapaport and Rao 1995). The two models are not mutually exclusive, and in any event, the central roles of tissue factor and factor VIIa in generating an initial supply of factors IXa and Xa, and the self-limiting nature of the process due to the action of TFPI, are all well-established.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep221">
 <bp:stepProcess rdf:resource="#Catalysis62" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction196" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway36">
 <bp:pathwayOrder rdf:resource="#PathwayStep332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep357" />
 <bp:pathwayOrder rdf:resource="#PathwayStep323" />
 <bp:pathwayComponent rdf:resource="#Pathway39" />
 <bp:pathwayComponent rdf:resource="#Pathway38" />
 <bp:pathwayComponent rdf:resource="#Pathway37" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Fibrin Clot (Clotting Cascade)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The formation of a fibrin clot at the site of an injury to the wall of a normal blood vessel is an essential part of the process to stop blood loss after vascular injury.  The reactions that lead to fibrin clot formation are commonly described as a cascade, in which the product of each step is an enzyme or cofactor needed for following reactions to proceed efficiently.  The entire clotting cascade can be divided into three portions, the extrinsic pathway, the intrinsic pathway, and the common pathway.  The extrinsic pathway begins with the release of tissue factor at the site of vascular injury and leads to the activation of factor X.  The intrinsic pathway provides an alternative mechanism for activation of factor X, starting from the activation of factor XII.  The common pathway consists of the steps linking the activation of factor X to the formation of a multimeric, cross-linked fibrin clot.  Each of these pathways includes not only a cascade of events that generate the catalytic activities needed for clot formation, but also numerous positive and negative regulatory events.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep220">
 <bp:stepProcess rdf:resource="#Catalysis61" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction195" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway35">
 <bp:pathwayOrder rdf:resource="#PathwayStep310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep313" />
 <bp:pathwayOrder rdf:resource="#PathwayStep312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction272" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tie2 Signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Tie2/Tek receptor tyrosine kinase plays a pivotal role in vascular and hematopoietic development and is expressed exclusively on endothelial lineage. Tie2 interacts with a group of ligands belonging to angiopoietin family and undergoes activation. These ligands show opposing actions, angiopoietin 1 and angiopoietin 4 stimulate the Tie2 phosphorylation and angiopoietin 2 inhibits it. Upon tyrosine phosphorylation Tie2 acts as a scaffold for various signaling proteins involved in different signal transduction cascades that can effect survival of endothelium and angiogenic sprout formation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway34">
 <bp:pathwayOrder rdf:resource="#PathwayStep295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep298" />
 <bp:pathwayOrder rdf:resource="#PathwayStep297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction261" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PECAM1 interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PECAM-1/CD31 is a member of the immunoglobulin superfamily (IgSF) and has been implicated to mediate the adhesion and trans-endothelial migration of T-lymphocytes into the vascular wall, T cell activation and angiogenesis. It has six Ig homology domains within its extracellularly and an ITIM motif within its cytoplasmic region. PECAM-1 mediates cellular interactions by both homophilic and heterophilic interactions. The cytoplasmic domain of PECAM-1 contains tyrosine residues which serves as docking sites for recruitment of cytosolic signaling molecules. Under conditions of platelet activation, PECAM-1 is phosphorylated by Src kinase members. The tyrosine residues 663 and 686 are required for recruitment of the SH2 domain containing PTPs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep226">
 <bp:stepProcess rdf:resource="#Catalysis64" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction199" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway33">
 <bp:pathwayOrder rdf:resource="#PathwayStep290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep283" />
 <bp:pathwayOrder rdf:resource="#PathwayStep282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction249" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction256" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction250" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Basigin is a widely expressed transmembrane glycoprotein that belongs to the Ig superfamily and is highly enriched on the surface of epithelial cells. Basigin is involved in intercellular interactions involved in various immunologic phenomena, differentiation, and development, but a major function of basigin is stimulation of synthesis of several matrix metalloproteinases.  Basigin also induces angiogenesis via stimulation of VEGF production. Basigin has an extracellular region with two Ig-like domains of which the N-term Ig-like domain is involved in interactions. It undergoes interactions between basigin molecules on opposing cells or on neighbouring cells. It also interacts with a variety of other proteins like caveolin-1, cyclophilins, integrins and annexin II that play important roles in cell proliferation, energy metabolism, migration, adhesion and motion, especially in cancer metastasis.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep225">
 <bp:stepProcess rdf:resource="#Pathway28" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway32">
 <bp:pathwayOrder rdf:resource="#PathwayStep280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep265" />
 <bp:pathwayOrder rdf:resource="#PathwayStep320" />
 <bp:pathwayOrder rdf:resource="#PathwayStep264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep269" />
 <bp:pathwayOrder rdf:resource="#PathwayStep302" />
 <bp:pathwayOrder rdf:resource="#PathwayStep268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep317" />
 <bp:pathwayOrder rdf:resource="#PathwayStep319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep258" />
 <bp:pathwayOrder rdf:resource="#PathwayStep257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction238" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction236" />
 <bp:pathwayComponent rdf:resource="#Pathway35" />
 <bp:pathwayComponent rdf:resource="#Pathway34" />
 <bp:pathwayComponent rdf:resource="#Pathway33" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction283" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell surface interactions at the vascular wall</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leukocyte extravasation is a rigorously controlled process that guides white cell movement from the vascular lumen to sites of tissue inflammation. The powerful adhesive interactions that are required for leukocytes to withstand local flow at the vessel wall is a multistep process mediated by different adhesion molecules. Platelets adhered to injured vessel walls form strong adhesive substrates for leukocytes. For instance, the initial tethering and rolling of leukocytes over the site of injury are mediated by reversible binding of selectins to their cognate cell-surface glycoconjugates.  Endothelial cells are tightly connected through various proteins, which regulate the organization of the junctional complex and bind to cytoskeletal proteins or cytoplasmic interaction partners that allow the transfer of intracellular signals. An important role for these junctional proteins in governing the transendothelial migration of leukocytes under normal or inflammatory conditions has been established.  This pathway describes some of the key interactions that assist in the process of platelet and leukocyte interaction with the endothelium, in response to injury.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep224">
 <bp:stepProcess rdf:resource="#Pathway27" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway31">
 <bp:pathwayOrder rdf:resource="#PathwayStep249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction218" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction220" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prostacyclin signalling through prostacyclin receptor</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prostacyclin (PGI2) is continuously produced by healthy vascular endothelial cells. It inhibits platelet activation through interaction with the Gs-coupled receptor PTGIR, leading to increased cAMP, a consequent increase in cAMP-dependent protein kinase activity which prevents increases of cytoplasmic [Ca2+] necessary for activation (Woulfe et al. 2001). PGI2 is also an effective vasodilator. These effects oppose the effects of thromboxane (TXA2), another eicosanoid, creating a balance of blood circulation and platelet activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep223">
 <bp:stepProcess rdf:resource="#Catalysis63" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction198" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway30">
 <bp:pathwayOrder rdf:resource="#PathwayStep239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction210" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet sensitization by LDL</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Physiological concentrations (1g/L) of Low density lipoprotein (LDL) enhance platelet aggregation responses initiated by thrombin, collagen, and ADP. This enhancement involves the rapid phosphorylation of p38 mitogen-activated protein kinase (p38MAPK) at Thr180 and Tyr182. The receptor for LDL is ApoER2, a splice variant of the classical ApoE receptor. ApoER2 stimulation leads to association of the Src family kinase Fgr which is probably responsible for subsequent phosphorylation of p38MAPK. This stimulation is transient because LDL also increases the activity of PECAM-1, which stimulates phosphatases that dephosphorylate p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction194" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction193" />
 <bp:stepProcess rdf:resource="#Catalysis60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction192" />
 <bp:stepProcess rdf:resource="#Catalysis59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep216">
 <bp:stepProcess rdf:resource="#Pathway26" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway39">
 <bp:pathwayOrder rdf:resource="#PathwayStep361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep382" />
 <bp:pathwayOrder rdf:resource="#PathwayStep381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep364" />
 <bp:pathwayOrder rdf:resource="#PathwayStep386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep371" />
 <bp:pathwayOrder rdf:resource="#PathwayStep370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep379" />
 <bp:pathwayOrder rdf:resource="#PathwayStep378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction339" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction332" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction333" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction347" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction343" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction340" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Common Pathway of Fibrin Clot Formation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The common pathway consists of the cascade of activation events leading from the formation of activated factor X to the formation of active thrombin, the cleavage of fibrinogen by thrombin, and the formation of cleaved fibrin into a stable multimeric, cross-linked complex.  Thrombin also efficiently catalyzes the activation of several factors  required earlier in the clotting cascade, thus acting in effect as a positive regulator of clotting.  At the same time, thrombin activates protein C, which in turn catalyzes the inactivation of several of these upstream factors, thereby  limiting the clotting process.  Thrombin can be trapped in stable, inactive complexes with: antithrombin-III (SERPINC1), a circulating blood protein; heparin cofactor II (SERPIND1) which inhibits thrombin in a dermatan sulfate&#8211;dependent manner in the arterial vasculature; protein C inhibitor (SERPINA5) that inhibits thrombin in complex with thrombomodulin; and Protease nexin-1 (SERPINE2) that inhibits thrombin at the vessel wall and platelet surface.  The quantitative interplay among these positive and negative modulators is critical to the normal regulation of clotting, facilitating the rapid formation of a protective clot at the site of injury, while limiting and physically confining the process. These events are outlined in the drawing: black arrows connect the substrates (inputs) and products (outputs) of individual reactions, and blue lines connect output activated enzymes to the other reactions that they catalyze.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway38">
 <bp:pathwayOrder rdf:resource="#PathwayStep350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep342" />
 <bp:pathwayOrder rdf:resource="#PathwayStep353" />
 <bp:pathwayOrder rdf:resource="#PathwayStep341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep335" />
 <bp:pathwayOrder rdf:resource="#PathwayStep346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction303" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction304" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction296" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Intrinsic Pathway of Fibrin Clot Formation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The intrinsic pathway of blood clotting connects interactions among kininogen (high molecular weight kininogen, HK), prekallikrein (PK), and factor XII to the activation of clotting factor X by a series of reactions that is independent of the extrinsic pathway and that is not subject to inhibition by TFPI. It is thus essential for the prolongation of the clotting cascade: while the reactions of the extrinsic pathway appear to be sufficient to initiate clot formation, those of the intrinsic pathway are required to maintain it (Broze 1995; Davie et al. 1991; Monroe et al. 2002). The intrinsic pathway can be divided into three parts: 1) reactions involving interactions of kininogen, prekallikrein, and factor XII, leading to the activation of factor XII, 2) reactions involving factor XI, factor IX, factor VIII, and von Willebrand factor (vWF) leading to the activation of factors VIII and IX, and 3) reactions that inactivate factor XIIa and kallikrein. Kininogen, prekallikrein, and factor XII were first identified as proteins needed for the rapid formation of clots when whole blood is exposed to negatively charged surfaces in vitro. Early studies in vitro identified several possible sets of interactions, in which small quantities of one or more of these proteins &apos;autoactivate&apos; and then catalyze the formation of larger quantities of activated factors. Subsequent work, however, suggests that these factors form complexes on endothelial cell surfaces mediated by C1q binding protein (C1q bp), that the first activation event is the cleavage of prekallikrein by prolylcarboxypeptidase, and that the resulting kallikrein catalyzes the activation of factor XII (Schmaier 2004). The second group of events, occurs in vivo on the surfaces of activated platelets (although most biochemical characterization of the reactions was originally done with purified proteins in solution). Factor XI binds to the platelet glycoprotein (GP) Ib:IX:V complex, where it can be activated by cleavage either by thrombin (generated by reactions of the common pathway) or by activated factor XII (generated in the first part of the intrinsic pathway). Activated factor XI in turn catalyzes the activation of factor IX. Simultaneously, factor VIII, complexed with vWF, is cleaved by thrombin, activating it and causing its release from vWF. Activated factors VIII and IX form a complex on the platelet surface that very efficiently converts factor X to activated factor X. (Activated factors X and V then form a complex that efficiently activates thrombin.) While these two groups of events can be viewed as forming a single functional pathway (e.g., Davie et al. 1991), human clinical genetic data cast doubt on this view. Individuals deficient in kininogen, prekallikrein, or factor XII proteins exhibit normal blood clot formation in vivo. In contrast, deficiencies of factor XI can be associated with failure of blood clotting under some conditions, and deficiencies of vWF, factor VIII, or factor IX cause severe abnormalities - von Willebrand disease, hemophilia A, and hemophilia B, respectively. These data suggest that while the second group of events is essential for normal clot formation in vivo, the first group has a different function (e.g., Schmaier 2004). Finally, reactions neutralize proteins activated in the first part of the intrinsic pathway. Kallikrein forms stable complexes with either C1 inhibitor (C1Inh) or with alpha2-macroglobulin, and factor XIIa forms stable complexes with C1Inh. The relevance of these neutralization events to the regulation of blood clotting is unclear, however. The physiological abnormalities observed in individuals who lack C1Inh appear to be due entirely to abnormalities of complement activation; blood clotting appears to proceed normally. This observation is consistent with the hypothesis, above, that factor XIIa plays a limited role in normal blood clotting under physiological conditions.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway26">
 <bp:pathwayOrder rdf:resource="#PathwayStep219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction195" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cGMP effects</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cyclic guanosine monophosphate (cGMP) is an important secondary messenger synthesized by guanylate cyclases. cGMP has effects on phosphodiesterases (PDE), ion-gated channels, and the cGMP-dependent protein kinases (cGK, Protein Kinase G or PKG). It is involved in regulation of  several physiological functions including vasodilation, platelet aggregation and neurotransmission.  Elevation of intracellular cGMP activates PKG (Haslam et al. 1999) which regulates several intracellular molecules and pathways including the vasodilator-stimulated phosphoprotein (VASP) (Halbrugge et al. 1990) and the ERK pathway (Hood and Granger 1998, Li et al. 2001). cGMP mediates nitric oxide (NO)-induced vascular smooth muscle relaxation (Furchgott and Vanhoutte 1989). Phosphodiesterase 5 (PDE5) hydrolyzes cGMP; the PDE5 inhibitor sildenafil (Viagra) increases intracellular cGMP and thereby can be used as a treatment for erectile dysfunction (Corbin and Francis 1999). The role of the cGMP and PKG in platelet activation was controversial as increases in platelet cGMP levels were observed in response to both platelet agonists (thrombin, ADP or collagen) and inhibitors (NO donors such as sodium nitroprusside), but it is currently accepted that PKG inhibits platelet activation (Haslam et al. 1999). Consistent with this, nitric oxide (NO) donors that inhibit platelet activation enhance intracellular cGMP (Haslam et al. 1999). cGMP also plays an important stimulatory role in GPIb-IX-mediated platelet activation. Platelet responses to cGMP have been proposed to be biphasic, consisting of an early stimulatory response that promotes platelet activation followed by a delayed platelet inhibition that serves to limit the size of platelet aggregates  (Li et al 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction205" />
 <bp:stepProcess rdf:resource="#Catalysis69" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway25">
 <bp:pathwayOrder rdf:resource="#PathwayStep216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep223" />
 <bp:pathwayComponent rdf:resource="#Pathway26" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction197" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide stimulates guanylate cyclase</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric Oxide (NO) inhibits smooth muscle cell proliferation and migration, oxidation of low-density lipoproteins, and platelet aggregation and adhesion. It can stimulate vasodilatation of the endothelium, disaggregation of  preformed platelet aggregates and inhibits activated platelet recruitment to the aggregate. NO is synthesized from L-arginine by a family of isoformic enzymes known as nitric oxide synthase (NOS). Three isoforms, namely endothelial, neuronal, and inducible NOS (eNOS, nNOS, and iNOS, respectively), have been identified. The eNOS isoform is found in the endothelium and platelets. NO regulation of cyclic guanosine-3,5-monophosphate (cGMP), via activation of soluble guanylate cyclase, is the principal mechanism of negative control over platelet activity. Defects in this control mechanism have been associated with platelet hyperaggregability and associated  thrombosis.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction204" />
 <bp:stepProcess rdf:resource="#Catalysis68" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway24">
 <bp:pathwayOrder rdf:resource="#PathwayStep251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep245" />
 <bp:pathwayComponent rdf:resource="#Pathway27" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction222" />
 <bp:pathwayComponent rdf:resource="#Pathway25" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction221" />
 <bp:pathwayComponent rdf:resource="#Pathway31" />
 <bp:pathwayComponent rdf:resource="#Pathway30" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet homeostasis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Under normal conditions the vascular endothelium supports vasodilation, inhibits platelet adhesion and activation, suppresses coagulation, enhances fibrin cleavage and is anti-inflammatory in character. Under acute vascular trauma, vasoconstrictor mechanisms predominate and the endothelium becomes prothrombotic, procoagulatory and proinflammatory in nature. This is achieved by a reduction of endothelial dilating agents: adenosine, NO and prostacyclin; and by the direct action of ADP, serotonin and thromboxane on vascular smooth muscle cells to elicit their contraction (Becker et al. 2000).  Cyclooxygenase-2 (COX-2) and endothelial nitric oxide synthase (eNOS) are primarily expressed in endothelial cells. Both are important regulators of vascular function. Under normal conditions, laminar flow induces vascular endothelial COX-2 expression and synthesis of Prostacyclin (PGI2) which in turn stimulates endothelial Nitric Oxide Synthase (eNOS) activity. PGI2 and NO both oppose platelet activation and aggregation, as does the CD39 ecto-ADPase, which decreases platelet activation and recruitment by metabolizing platelet-released ADP. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep231">
 <bp:stepProcess rdf:resource="#Pathway29" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway23">
 <bp:pathwayOrder rdf:resource="#PathwayStep208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep210" />
 <bp:pathwayOrder rdf:resource="#PathwayStep213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction191" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction184" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet Adhesion to exposed collagen</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Initiation of platelet adhesion is the first step in the formation of the platelet plug. Circulating platelets are arrested and subsequently activated by exposed collagen and von Willebrand factor (VWF). It is not entirely clear which type of collagen is responsible for adhesion and activation; collagen types I and III are abundant in vascular epithelia but several other types including IV are present (Farndale RW 2006). Several collagen binding proteins are expressed on platelets, including integrin alpha2 beta1 (&#945;2&#946;1 or ITGA2:ITGB1), GPVI, and GPIV. ITGA2:ITGB1, known on leukocytes as VLA-2, is the major platelet collagen receptor (Kunicki TJ et al., 1988). ITGA2:ITGB1 (&#945;2&#946;1) requires Mg2+ to interact with collagen. The activation of ITGA2:ITGB1 (&#945;2&#946;1) is modulated by the activation of integrin alphaIIb beta3 (&#945;IIb&#946;3 or ITGA2B:ITGB3), which functions as a platelet receptor for fibrinogen and VWF (van de Walle GR et al., 2007). The I domain of &#945;2 (ITGA2) subunit binds a collagen motif with the sequence Gly-Phe-Hyp-Gly-Glu-Arg (Emsley J et al., 2000). Binding of collagen to ITGA2:ITGB1 (&#945;2&#946;1) generates intracellular signals that contribute to platelet activation. These interactions facilitate the engagement of the lower-affinity collagen receptor, GPVI (Tsuji M et al., 1997), the key receptor involved in collagen-induced platelet activation. The GPVI receptor is a complex of the GPVI protein with a dimer of Fc epsilon R1 gamma (FceRI gamma). The Src family kinases Fyn and Lyn constitutively associate with the GPVI:FceRIgamma complex in platelets and initiate platelet activation through phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) in FceRI gamma, leading to binding and activation of the tyrosine kinase Syk. Downstream of Syk, a series of adapter molecules and effectors lead to platelet activation. VWF circulates in plasma as a multimeric molecule that senses hydrodynamic shear forces in the bloodstream (Reininger AJ 2008; Mojzisch A    Brehm MA 2021). Upon vascular injury, circulating VWF binds to subendothelial collagen, which becomes exposed to the flowing blood (Bergmeier W    Hynes RO 2012; Colace TV    Diamond SL 2013). Upon binding to collagen, VWF becomes anchored to the damaged surface. Shear forces then induce conformational changes to mechanosensitive VWF causing the bound VWF to stretch and unfold (Li F et al., 2004; Schneider SW et al., 2007; Fu H et al., 2017). VWF unfolding leads to exposure of the A1 domain to allow binding to glycoprotein Ib &#945; (GPIb&#945;, encoded by GP1BA), a subunit of the platelet surface GPIb:IX:V complex (Dumas JJ et al., 2004; Ju L et al., 2013). Shear-induced aggregation is achieved when VWF interacts both with exposed collagen and platelets to initiate platelet adhesion to vascular injury sites. The interaction between VWF and GPIb is regulated by shear force; an increase in the shear stress results in a corresponding increase in the affinity of VWF for GPIb.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep230">
 <bp:stepProcess rdf:resource="#Catalysis67" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction203" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway22">
 <bp:pathwayOrder rdf:resource="#PathwayStep192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep203" />
 <bp:pathwayOrder rdf:resource="#PathwayStep202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction180" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction173" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissolution of Fibrin Clot</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The crosslinked fibrin multimers in a clot are broken down to soluble polypeptides by plasmin, a serine protease. Plasmin can be generated from its inactive precursor plasminogen and recruited to the site of a fibrin clot in two ways, by interaction with tissue plasminogen activator at the surface of a fibrin clot, and by interaction with urokinase plasminogen activator at a cell surface. The first mechanism appears to be the major one responsible for the dissolution of clots within blood vessels. The second, although capable of mediating clot dissolution, may normally play a major role in tissue remodeling, cell migration, and inflammation (Chapman 1997; Lijnen 2001). Clot dissolution is regulated in two ways. First, efficient plasmin activation and fibrinolysis occur only in complexes formed at the clot surface or on a cell membrane - proteins free in the blood are inefficient catalysts and are rapidly inactivated. Second, both plasminogen activators and plasmin itself are inactivated by specific serpins, proteins that bind to serine proteases to form stable, enzymatically inactive complexes (Kohler and Grant 2000). These events are outlined in the drawing: black arrows connect the substrates (inputs) and products (outputs) of individual reactions, and blue lines connect output activated enzymes to the other reactions that they catalyze.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep237">
 <bp:stepProcess rdf:resource="#BiochemicalReaction208" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway21">
 <bp:pathwayOrder rdf:resource="#PathwayStep181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction160" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction161" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Arachidonate production from DAG</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Diacylglycerol (DAG) is an important source of arachidonic acid, a signalling molecule and the precursor of the prostaglandins. In human platelet almost all the DAG produced from phosphatidylinositol degradation contains arachidonate (Takamura et al. 1987). DAG is hydrolysed by DAG lipase to 2-arachidonylglycerol (2-AG) which is further hydrolysed by monoacylglycerol lipase. 2-AG is an agonist of cannabinoid receptor 1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep236">
 <bp:stepProcess rdf:resource="#BiochemicalReaction207" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway20">
 <bp:pathwayOrder rdf:resource="#PathwayStep174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction155" />
 <bp:pathwayComponent rdf:resource="#Pathway21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction162" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Effects of PIP2 hydrolysis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of phosphatidyl inositol-bisphosphate (PIP2) by phospholipase C (PLC) produces diacylglycerol (DAG) and inositol triphosphate (IP3). Both are potent second messengers. IP3 diffuses into the cytosol, but as DAG is a hydrophobic lipid it remains within the plasma membrane. IP3 stimulates the release of calcium ions from the smooth endoplasmic reticulum, while DAG activates the conventional and unconventional protein kinase C (PKC) isoforms, facilitating the translocation of PKC from the cytosol to the plasma membrane. The effects of DAG are mimicked by tumor-promoting phorbol esters. DAG is also a precursor for the biosynthesis of prostaglandins, the endocannabinoid 2-arachidonoylglycerol and an activator of a subfamily of TRP-C (Transient Receptor Potential Canonical) cation channels 3, 6, and 7.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep235">
 <bp:stepProcess rdf:resource="#Pathway30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction206" />
 <bp:stepProcess rdf:resource="#Catalysis70" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep229">
 <bp:stepProcess rdf:resource="#BiochemicalReaction202" />
 <bp:stepProcess rdf:resource="#Catalysis66" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep228">
 <bp:stepProcess rdf:resource="#BiochemicalReaction201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep227">
 <bp:stepProcess rdf:resource="#Catalysis65" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction200" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway29">
 <bp:pathwayOrder rdf:resource="#PathwayStep233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction205" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reduction of cytosolic Ca++ levels</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">During steady state conditions, cytoplasmic [Ca2+] is reduced by the accumulation of Ca2+ in intracellular stores and Ca2+ extrusion.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway28">
 <bp:pathwayOrder rdf:resource="#PathwayStep229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction199" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Elevation of cytosolic Ca2+ levels</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of non- excitable cells involves the agonist-induced elevation of cytosolic Ca2+, an essential process for platelet activation. It occurs through Ca2+ release from intracellular stores and Ca2+ entry through the plasma membrane. Ca2+ store release involves phospholipase C (PLC)-mediated production of inositol-1,4,5-trisphosphate (IP3), which in turn stimulates IP3 receptor channels to release Ca2+ from intracellular stores. This is followed by Ca2+ entry into the cell through plasma membrane calcium channels, a process referred to as store-operated calcium entry (SOCE). Stromal interaction molecule 1 (STIM1), a Ca2+ sensor molecule in intracellular stores, and the four transmembrane channel protein Orai1 are the key players in platelet SOCE. Other major Ca2+ entry mechanisms are mediated by the direct receptor-operated calcium (ROC) channel, P2X1 and transient receptor potential channels (TRPCs).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway27">
 <bp:pathwayOrder rdf:resource="#PathwayStep231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep225" />
 <bp:pathwayComponent rdf:resource="#Pathway29" />
 <bp:pathwayComponent rdf:resource="#Pathway28" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet calcium homeostasis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ca2+ homeostasis is controlled by processes that elevate or counter the elevation of cytosolic Ca2+.  During steady state conditions, cytoplasmic Ca2+ is reduced by the accumulation of Ca2+ in intracellular stores and by Ca2+ extrusion. The primary intracellular calcium store in platelets is the dense tubular system, the equivalent of the ER system in other cell types. Ca2+ is extruded by Ca2+-ATPases including plasma membrane Ca2+ ATPases (PMCAs) and sarco/endoplasmic reticulum Ca2+ -ATPase isoforms (SERCAs).   Activation of non- excitable cells involves the agonist-induced elevation of cytosolic Ca2+, an essential process for platelet activation. It occurs through Ca2+ release from intracellular stores and Ca2+ entry through the plasma membrane. Ca2+ store release involves phospholipase C (PLC)-mediated production of inositol-1,4,5-trisphosphate (IP3), which in turn stimulates IP3 receptor channels to release Ca2+ from intracellular stores. This is followed by Ca2+ entry into the cell through plasma membrane calcium channels, a process referred to as store-operated calcium entry (SOCE). Stromal interaction molecule 1 (STIM1), a Ca2+ sensor molecule in intracellular stores, and the four transmembrane channel protein Orai1 are the key players in platelet SOCE. Other major Ca2+ entry mechanisms are mediated by the direct receptor-operated calcium (ROC) channel, P2X1 and transient receptor potential channels (TRPCs).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway15">
 <bp:pathwayOrder rdf:resource="#PathwayStep117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction103" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adrenaline signalling through Alpha-2 adrenergic receptor</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adrenaline (epinephrine) signalling via the alpha-2 adrenergic receptor has many effects including inhibition of insulin release in pancreas, induction of glucagon release from pancreas, contraction of sphincters of the gastrointestinal tract, negative feedback processes in neuronal synapses and stimulation of platelet aggregation. This receptor preferentially couples to members of the Gi class of heterotrimeric G-proteins, leading to inhibition af adenylate cyclase and thereby decreased cAMP levels.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep200">
 <bp:stepProcess rdf:resource="#BiochemicalReaction179" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway14">
 <bp:pathwayOrder rdf:resource="#PathwayStep118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction128" />
 <bp:pathwayComponent rdf:resource="#Pathway16" />
 <bp:pathwayComponent rdf:resource="#Pathway15" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction102" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet Aggregation (Plug Formation)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The tethering of platelets to the site of vascular injury is the first step in the formation of a platelet thrombus. Firm adhesion of these tethered platelets, as well as the additional recruitment of others onto their surface leads to the formation of large platelet aggregates. The formation of a thrombus is strictly dependent on the formation of interplatelet bonds.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway13">
 <bp:pathwayOrder rdf:resource="#PathwayStep101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep99" />
 <bp:pathwayOrder rdf:resource="#PathwayStep98" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction92" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction93" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction94" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction90" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction88" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction99" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction89" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction95" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction96" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction86" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction97" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction87" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction98" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction100" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence98" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin signalling through proteinase activated receptors (PARs)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin activates proteinase activated receptors (PARs) that signal through heterotrimeric G proteins of the G12/13 and Gq families, thereby connecting to a host of intracellular signaling pathways. Thrombin activates PARs by cleaving an N-terminal peptide that then binds to the body of the receptor to effect transmembrane signaling. Intermolecular ligation of one PAR molecule by another can occur but is less efficient than self-ligation. A synthetic peptide of sequence SFLLRN, the first six amino acids of the new N-terminus generated when thrombin cleaves PAR1, can activate PAR1 independent of protease and receptor cleavage. PARs are key to platelet activation. Four PARs have been identified, of which PARs 1 ,3 and 4 are substrates for thrombin. In humans PAR 1 is the predominant thrombin receptor followed by PAR4 which is less responsive to thrombin. PAR 3 is not considered important for human platelet responses as it is minimally expressed, though this is not the case for mouse. PAR2 is not expressed in platelets. In mouse platelets, Gq is necessary for platelet secretion and aggregation in response to thrombin but is not necessary for thrombin-triggered shape change. G13 appears to contribute to platelet aggregation as well as shape change in response to low concentrations of thrombin but to be unnecessary at higher agonist concentrations; G12 appears to be dispensable for thrombin signaling in platelets. G alpha (q) activates phospholipase C beta thereby triggering phosphoinositide hydrolysis, calcium mobilization and protein kinase C activation. This provides a path to calcium-regulated kinases and phosphatases, GEFs, MAP kinase cassettes and other proteins that mediate cellular responses ranging from granule secretion, integrin activation, and aggregation in platelets. Gbeta:gamma subunits can activate phosphoinositide-3 kinase and other lipid modifying enzymes, protein kinases, and channels. PAR1 activation indirectly leads to activation of cell surface &apos;sheddases&apos; that liberate ligands for receptor tyrosine kinases, providing a link between thrombin and receptor tyrosine kinases involved in cell growth and differentiation. The pleiotrophic effects of PAR activation are consistent with many of thrombin&apos;s diverse actions on cells. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway12">
 <bp:pathwayOrder rdf:resource="#PathwayStep89" />
 <bp:pathwayOrder rdf:resource="#PathwayStep91" />
 <bp:pathwayOrder rdf:resource="#PathwayStep90" />
 <bp:pathwayOrder rdf:resource="#PathwayStep95" />
 <bp:pathwayOrder rdf:resource="#PathwayStep94" />
 <bp:pathwayOrder rdf:resource="#PathwayStep93" />
 <bp:pathwayOrder rdf:resource="#PathwayStep92" />
 <bp:pathwayOrder rdf:resource="#PathwayStep88" />
 <bp:pathwayOrder rdf:resource="#PathwayStep87" />
 <bp:pathwayOrder rdf:resource="#PathwayStep86" />
 <bp:pathwayOrder rdf:resource="#PathwayStep96" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction77" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction78" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction79" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction84" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction85" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction75" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction76" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction80" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction81" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction82" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction83" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence86" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet degranulation </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelets function as exocytotic cells, secreting a plethora of effector molecules at sites of vascular injury. Platelets contain a number of distinguishable storage granules including alpha granules, dense granules and lysosomes. On activation platelets release a variety of proteins, largely from storage granules but also as the result of apparent cell lysis. These act in an autocrine or paracrine fashion to modulate cell signaling.     Alpha granules contain mainly polypeptides such as  fibrinogen, von Willebrand factor, growth factors and protease inhibitors that that supplement thrombin generation at the site of injury. Dense granules contain small molecules, particularly adenosine diphosphate (ADP), adenosine triphosphate (ATP), serotonin and calcium, all recruit  platelets to the site of injury.  The molecular mechanism which facilitates granule release involves soluble NSF attachment protein receptors (SNAREs), which assemble into complexes to form a universal membrane fusion apparatus. Although all cells use SNAREs for membrane fusion, different cells possess different SNARE isoforms. Platelets and chromaffin cells use many of the same chaperone proteins to regulate SNARE-mediated secretion (Fitch-Tewfik    Flaumenhaft 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway11">
 <bp:pathwayOrder rdf:resource="#PathwayStep84" />
 <bp:pathwayOrder rdf:resource="#PathwayStep83" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction73" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction74" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence83" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disinhibition of SNARE formation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The SNARE (SNAp REceptor) family of proteins are critical components of the machinery required for membrane fusion (S&#246;llner et al. 1993, Wu et al. 2017). SNAREs can be grouped into three broad subfamilies: synaptosomal-associated proteins (SNAPs), vesicle-associated membrane proteins (VAMPs) and syntaxins. SNAPs contain two SNARE motifs and lack transmembrane domains, instead they are anchored to the membrane by thioester-linked acyl groups (Hong 2005). VAMPS or  R-SNAREs have two subfamilies: short VAMPs or brevins and long VAMPs or longins. Syntaxins are evolutionarily less-well conserved, but except STX11 are transmembrane proteins (Hong 2005). Several SNARE proteins including Syntaxin-2 (STX2), STX4, STX11 and Vesicle-associated membrane protein 8 (VAMP8) are thought to be involved in platelet granule secretion (Golebiewska et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep204">
 <bp:stepProcess rdf:resource="#BiochemicalReaction183" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway10">
 <bp:pathwayOrder rdf:resource="#PathwayStep82" />
 <bp:pathwayOrder rdf:resource="#PathwayStep81" />
 <bp:pathwayOrder rdf:resource="#PathwayStep85" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction72" />
 <bp:pathwayComponent rdf:resource="#Pathway12" />
 <bp:pathwayComponent rdf:resource="#Pathway11" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence81" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Response to elevated platelet cytosolic Ca2+</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of phospholipase C enzymes results in the generation of second messengers of the phosphatidylinositol pathway. The events resulting from this pathway are a rise in intracellular calcium and activation of Protein Kinase C (PKC). Phospholipase C cleaves the phosphodiester bond in PIP2 to form 1,2 Diacylglycerol (DAG) and 1,4,5-inositol trisphosphate (IP3). IP3 opens Ca2+ channels in the platelet dense tubular system, raising intracellular Ca2+ levels. DAG is a second messenger that regulates a family of Ser/Thr kinases consisting of PKC isozymes (Nishizuka 1995). DAG achieves activation of PKC isozymes by increasing their affinity for phospholipid. Most PKC enzymes are also calcium-dependent, so their activation is in synergy with the rise in intracellular Ca2+. Platelets contain several PKC isoforms that can be activated by DAG and/or Ca2+ (Chang 1997).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction182" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction181" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep201">
 <bp:stepProcess rdf:resource="#BiochemicalReaction180" />
 <bp:stepProcess rdf:resource="#Catalysis57" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway19">
 <bp:pathwayOrder rdf:resource="#PathwayStep163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep155" />
 <bp:pathwayOrder rdf:resource="#PathwayStep154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep159" />
 <bp:pathwayOrder rdf:resource="#PathwayStep158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction150" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction140" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPVI-mediated activation cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The GPVI receptor is a complex of the GPVI protein with Fc epsilon R1 gamma (FcR). The Src family kinases Fyn and Lyn constitutively associate with the GPVI-FcR complex in platelets and initiate platelet activation through phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) in the FcR gamma chain, leading to binding and activation of the tyrosine kinase Syk. Downstream of Syk, a series of adapter molecules and effectors lead to platelet activation.   The GPVI receptor signaling cascade is similar to that of T- and B-cell immune receptors, involving the formation of a signalosome composed of adapter and effector proteins. At the core of the T-cell receptor signalosome is the transmembrane adapter LAT and two cytosolic adapters SLP-76 and Gads. While LAT is essential for signalling to PLCgamma1 downstream of the T-cell receptor, the absence of LAT in platelets only impairs the activation of PLCgamma2, the response to collagen and GPVI receptor ligands remains sufficient to elicit a full aggregation response. In contrast, GPVI signalling is almost entirely abolished in the absence of SLP-76.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence10">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway18">
 <bp:pathwayOrder rdf:resource="#PathwayStep141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction124" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS provides linkage to MAPK signaling for Integrins </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin signaling is linked to the MAP kinase pathway by recruiting Grb2 to the FADK1/SRC activation complex.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence11">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway17">
 <bp:pathwayOrder rdf:resource="#PathwayStep123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction106" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p130Cas linkage to MAPK signaling for integrins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin signaling is linked to the MAP kinase pathway by recruiting p130cas and Crk to the FAK/Src activation complex.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence12">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway16">
 <bp:pathwayOrder rdf:resource="#PathwayStep130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction119" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction126" />
 <bp:pathwayComponent rdf:resource="#Pathway18" />
 <bp:pathwayComponent rdf:resource="#Pathway17" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction120" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrins are a major family of cell surface receptors that modulate cell adhesion, migration, proliferation and survival through interaction with the extracellular matrix (ECM) and the actin cytoskeleton.  Integrins are type 1 transmembrane proteins that exist at the cell surface as heterodimers of alpha and beta subunits, of which there are 18 and 8 different isoforms, respectively, in human cells. In addition to their mechanical role in mediating contact between the ECM and the cytoskeleton, integrins also modulate intracellular signaling pathways governing cytoskeletal rearrangements and pro-survival and mitogenic signaling (reviewed in Hehlgans et al, 2007; Harburger and Calderwood, 2009; Ata and Antonescu, 2017).  In this pathway, we describe signaling through integrin alphaIIb beta3 as a representative example.  At the sites of vascular injury bioactive molecules such as thrombin, ADP, collagen, fibrinogen and thrombospondin are generated, secreted or exposed. These stimuli activate platelets, converting the major platelet integrin alphaIIbbeta3 from a resting state to an active conformation, in a process termed integrin priming or &apos;inside-out signalling&apos;. Integrin activation refers to the change required to enhance ligand-binding activity. The activated alphaIIbbeta3 interacts with the fibrinogen and links platelets together in an aggregate to form a platelet plug. AlphaIIbbeta3 bound to fibrin generates more intracellular signals (outside-in signalling), causing further platelet activation and platelet-plug retraction.  In the resting state the alpha and beta tails are close together.  This interaction keeps the membrane proximal regions in a bent conformation that maintains alphaIIbbeta3 in a low affinity state.  Integrin alphaIIbbeta3 is released from its inactive state by interaction with the protein talin. Talin interacts with the beta3 cytoplasmic domain and disrupts the salt bridge between the alpha and beta chains. This separation in the cytoplasmic regions triggers the conformational change in the extracellular domain that increases its affinity to fibrinogen.  Much of talin exists in an inactive cytosolic pool, and the Rap1 interacting adaptor molecule (RIAM) is implicated in talin activation and translocation to beta3 integrin cytoplasmic domain. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence13">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence14">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence15">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence16">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence17">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence18">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence19">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction189" />
 <bp:stepProcess rdf:resource="#Catalysis58" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep215">
 <bp:stepProcess rdf:resource="#Pathway25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep214">
 <bp:stepProcess rdf:resource="#Pathway24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep212">
 <bp:stepProcess rdf:resource="#BiochemicalReaction190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction186" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep207">
 <bp:stepProcess rdf:resource="#BiochemicalReaction185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep205">
 <bp:stepProcess rdf:resource="#Pathway23" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep209">
 <bp:stepProcess rdf:resource="#BiochemicalReaction187" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction80">
 <bp:evidence rdf:resource="#Evidence92" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of platelet secretory granule components</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction81">
 <bp:evidence rdf:resource="#Evidence93" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Surface deployment of platelet dense granule membrane components</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction82">
 <bp:evidence rdf:resource="#Evidence94" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of platelet cytosolic components</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction83">
 <bp:evidence rdf:resource="#Evidence95" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Surface deployment of platelet alpha granule membrane components</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence229">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence226">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence227">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep26">
 <bp:stepProcess rdf:resource="#BiochemicalReaction24" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction77">
 <bp:evidence rdf:resource="#Evidence89" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of Proactivator polypeptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction192">
 <bp:evidence rdf:resource="#Evidence218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cGMP is degraded by PDEs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence235">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep25">
 <bp:stepProcess rdf:resource="#BiochemicalReaction23" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction78">
 <bp:evidence rdf:resource="#Evidence90" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of platelet alpha granule contents</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction193">
 <bp:evidence rdf:resource="#Evidence219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKG1 phosphorylates IRAG:IP3R1 inhibiting IP3-stimulated Ca2+ release</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence236">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep24">
 <bp:stepProcess rdf:resource="#BiochemicalReaction22" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction79">
 <bp:evidence rdf:resource="#Evidence91" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of platelet dense granule content</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction190">
 <bp:evidence rdf:resource="#Evidence213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPVI binds Fyn and Lyn</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence233">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep23">
 <bp:stepProcess rdf:resource="#BiochemicalReaction21" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction191">
 <bp:evidence rdf:resource="#Evidence214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of GPVI:Fc Epsilon R1 gamma receptor complex with collagen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence234">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction73">
 <bp:evidence rdf:resource="#Evidence84" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of Syntaxin-4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence231">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep29">
 <bp:stepProcess rdf:resource="#BiochemicalReaction27" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction74">
 <bp:evidence rdf:resource="#Evidence85" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of Platelet Sec-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence232">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep28">
 <bp:stepProcess rdf:resource="#BiochemicalReaction26" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction75">
 <bp:evidence rdf:resource="#Evidence87" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of 78 kDa glucose-regulated protein</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep27">
 <bp:stepProcess rdf:resource="#BiochemicalReaction25" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction76">
 <bp:evidence rdf:resource="#Evidence88" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of Calumenin </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence230">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction198">
 <bp:evidence rdf:resource="#Evidence224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric Oxide Synthase (NOS) produces Nitric Oxide (NO)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction199">
 <bp:evidence rdf:resource="#Evidence227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2X1-mediated entry of Ca++ from plasma</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep22">
 <bp:stepProcess rdf:resource="#BiochemicalReaction20" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction196">
 <bp:evidence rdf:resource="#Evidence222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Soluble guanylate cyclase converts GTP to cGMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep21">
 <bp:stepProcess rdf:resource="#BiochemicalReaction19" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction197">
 <bp:evidence rdf:resource="#Evidence223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NO binds to Guanylate Cyclase</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep20">
 <bp:stepProcess rdf:resource="#BiochemicalReaction18" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction194">
 <bp:evidence rdf:resource="#Evidence220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cGMP stimulates Protein Kinase G</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction195">
 <bp:evidence rdf:resource="#Evidence221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKG1 phosphorylates BK channels</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction70">
 <bp:evidence rdf:resource="#Evidence79" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AAMP binds to TBXA2R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction71">
 <bp:evidence rdf:resource="#Evidence80" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of the TP:G13 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence219">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction72">
 <bp:evidence rdf:resource="#Evidence82" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of conventional Protein Kinase C</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence217">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence216">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep15">
 <bp:stepProcess rdf:resource="#BiochemicalReaction13" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction66">
 <bp:evidence rdf:resource="#Evidence75" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gq activation by TP receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence224">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep14">
 <bp:stepProcess rdf:resource="#BiochemicalReaction12" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction67">
 <bp:evidence rdf:resource="#Evidence76" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of the TP:Gq complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence225">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep13">
 <bp:stepProcess rdf:resource="#BiochemicalReaction11" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction68">
 <bp:evidence rdf:resource="#Evidence77" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP receptor can bind thromboxane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence222">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep12">
 <bp:stepProcess rdf:resource="#Pathway3" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction69">
 <bp:evidence rdf:resource="#Evidence78" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G13 activation by TP receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence223">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep19">
 <bp:stepProcess rdf:resource="#BiochemicalReaction17" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction62">
 <bp:evidence rdf:resource="#Evidence70" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2RY1 binds ADP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence220">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep18">
 <bp:stepProcess rdf:resource="#BiochemicalReaction16" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction63">
 <bp:evidence rdf:resource="#Evidence71" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Src activation following P2Y purinoceptor activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence221">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep17">
 <bp:stepProcess rdf:resource="#BiochemicalReaction15" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction64">
 <bp:evidence rdf:resource="#Evidence73" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TP receptor binds G-protein  G13</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep16">
 <bp:stepProcess rdf:resource="#BiochemicalReaction14" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction65">
 <bp:evidence rdf:resource="#Evidence74" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TP receptor binds G-proten Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep11">
 <bp:stepProcess rdf:resource="#Catalysis5" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction10" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep10">
 <bp:stepProcess rdf:resource="#Catalysis4" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction9" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction9">
 <bp:evidence rdf:resource="#Evidence11" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MICAL1 produces NADP+, H2O2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction8">
 <bp:evidence rdf:resource="#Evidence10" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of globin genes under control of the beta globin control region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction7">
 <bp:evidence rdf:resource="#Evidence9" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITPK1 converts Ins-1,3,4-P3 to Ins-1,3,4,5-P4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction6">
 <bp:evidence rdf:resource="#Evidence8" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITPK1 converts Ins-1,3,4-P3 to Ins-1,3,4,6-P4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction5">
 <bp:evidence rdf:resource="#Evidence7" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dual-specific AKAPs bind type I and II PKA regulatory subunits</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction4">
 <bp:evidence rdf:resource="#Evidence6" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFE2 binds the beta globin locus control region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction60">
 <bp:evidence rdf:resource="#Evidence68" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gq activation by P2Y purinoceptor 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence208">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction61">
 <bp:evidence rdf:resource="#Evidence69" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated P2Y purinoceptor 1 binds G-protein Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence204">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence205">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep48">
 <bp:stepProcess rdf:resource="#BiochemicalReaction44" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction55">
 <bp:evidence rdf:resource="#Evidence62" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gi activation by P2Y purinoceptor 12</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence213">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep47">
 <bp:stepProcess rdf:resource="#Pathway5" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction56">
 <bp:evidence rdf:resource="#Evidence63" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2RY12 binds ADP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence214">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep46">
 <bp:stepProcess rdf:resource="#Pathway4" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction57">
 <bp:evidence rdf:resource="#Evidence65" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y purinoceptor 1 activates MAP kinase p38 alpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence211">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep45">
 <bp:stepProcess rdf:resource="#BiochemicalReaction43" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction58">
 <bp:evidence rdf:resource="#Evidence66" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of cPLA2 by MAPK p38 alpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence212">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction51">
 <bp:evidence rdf:resource="#Evidence56" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GP1b-IX-V binds filamin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction52">
 <bp:evidence rdf:resource="#Evidence57" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14-3-3-zeta binds Raf1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence210">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction53">
 <bp:evidence rdf:resource="#Evidence60" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of the P2Y purinoceptor 12:Gi complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep49">
 <bp:stepProcess rdf:resource="#BiochemicalReaction45" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction54">
 <bp:evidence rdf:resource="#Evidence61" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated P2Y purinoceptor 12 binds G-protein Gi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction3">
 <bp:evidence rdf:resource="#Evidence5" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cables link CDK5 and ABL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep40">
 <bp:stepProcess rdf:resource="#BiochemicalReaction38" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2">
 <bp:evidence rdf:resource="#Evidence4" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DOCKs bind to RhoGEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1">
 <bp:evidence rdf:resource="#Evidence3" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JMJD1C demethylates H3K9 mono- and di-methylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep44">
 <bp:stepProcess rdf:resource="#BiochemicalReaction42" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction59">
 <bp:evidence rdf:resource="#Evidence67" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of the P2Y purinoceptor 1:Gq complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep43">
 <bp:stepProcess rdf:resource="#BiochemicalReaction41" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep42">
 <bp:stepProcess rdf:resource="#BiochemicalReaction40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep41">
 <bp:stepProcess rdf:resource="#BiochemicalReaction39" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction50">
 <bp:evidence rdf:resource="#Evidence55" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-Src binds Raf1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep37">
 <bp:stepProcess rdf:resource="#BiochemicalReaction35" />
 <bp:stepProcess rdf:resource="#Catalysis6" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction44">
 <bp:evidence rdf:resource="#Evidence49" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPIb-IX-V binding to 14-3-3 zeta is reduced by shear stress</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence202">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep36">
 <bp:stepProcess rdf:resource="#BiochemicalReaction34" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction45">
 <bp:evidence rdf:resource="#Evidence50" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPIb-IX-V binds to vWF:Collagen complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence203">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep35">
 <bp:stepProcess rdf:resource="#BiochemicalReaction33" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction46">
 <bp:evidence rdf:resource="#Evidence51" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">vWF binds to collagen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence200">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep34">
 <bp:stepProcess rdf:resource="#BiochemicalReaction32" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction47">
 <bp:evidence rdf:resource="#Evidence52" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GP1b signaling involves c-Src</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence201">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction40">
 <bp:evidence rdf:resource="#Evidence43" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SH2B proteins bind JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction41">
 <bp:evidence rdf:resource="#Evidence44" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAD51B:RAD51C binds single-stranded DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep39">
 <bp:stepProcess rdf:resource="#BiochemicalReaction37" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction42">
 <bp:evidence rdf:resource="#Evidence45" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Interferon-alpha and beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep38">
 <bp:stepProcess rdf:resource="#BiochemicalReaction36" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction43">
 <bp:evidence rdf:resource="#Evidence46" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFE2 is a heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep33">
 <bp:stepProcess rdf:resource="#BiochemicalReaction31" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction48">
 <bp:evidence rdf:resource="#Evidence53" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GP1b-IX-V:13-3-3-zeta complexes with p85 PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep32">
 <bp:stepProcess rdf:resource="#BiochemicalReaction30" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction49">
 <bp:evidence rdf:resource="#Evidence54" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GP1b-IX-V binds 14-3-3-zeta</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep31">
 <bp:stepProcess rdf:resource="#BiochemicalReaction29" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep30">
 <bp:stepProcess rdf:resource="#BiochemicalReaction28" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction158">
 <bp:evidence rdf:resource="#Evidence178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG kinase produces phosphatidic acid from DAG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction159">
 <bp:evidence rdf:resource="#Evidence180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2-AG hydrolysis to arachidonate by MAGL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction33">
 <bp:evidence rdf:resource="#Evidence36" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cables1 links CDK2 and WEE1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction34">
 <bp:evidence rdf:resource="#Evidence37" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p53, SIN3A and MYB form a complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction35">
 <bp:evidence rdf:resource="#Evidence38" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate Kinase 3 is a GTP-AMP phosphotransferase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction36">
 <bp:evidence rdf:resource="#Evidence39" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EHD proteins interact with Rabenosyn-5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction30">
 <bp:evidence rdf:resource="#Evidence33" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mitofusins trans-interact linking mitochondria prior to fusion</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction31">
 <bp:evidence rdf:resource="#Evidence34" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HP1 alpha binds Histone H3K9(me)3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction32">
 <bp:evidence rdf:resource="#Evidence35" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">F-actin capping protein binds to the barbed end of elongating F-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction156">
 <bp:evidence rdf:resource="#Evidence176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG activation of TRPC channels</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction157">
 <bp:evidence rdf:resource="#Evidence177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of IP3 to IP3 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction154">
 <bp:evidence rdf:resource="#Evidence174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R tetramer:I(1,4,5)P3:4xCa2+ transports Ca2+ from platelet dense tubular system to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction155">
 <bp:evidence rdf:resource="#Evidence175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium and Diacylglycerol activate CalDAG-GEFs (RasGRPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction37">
 <bp:evidence rdf:resource="#Evidence40" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REST recruits the BHC complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction152">
 <bp:evidence rdf:resource="#Evidence171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y348-SYK dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction38">
 <bp:evidence rdf:resource="#Evidence41" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF2 binds the promoters of Interferon alpha and beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction153">
 <bp:evidence rdf:resource="#Evidence172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLP-76 stimulates PLC gamma 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction39">
 <bp:evidence rdf:resource="#Evidence42" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAD51B binds RAD51C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction150">
 <bp:evidence rdf:resource="#Evidence169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y348-SYK phosphorylates VAV family</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction151">
 <bp:evidence rdf:resource="#Evidence170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPVI stimulates PI3K beta, gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction169">
 <bp:evidence rdf:resource="#Evidence191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">urokinase plasminogen activator (two-chain):uPAR + plasminogen activator inhibitor 2 (PAI-2) -&gt; PAI-2:urokinase plasminogen activator (two-chain):uPAR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction22">
 <bp:evidence rdf:resource="#Evidence25" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-9 is a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction23">
 <bp:evidence rdf:resource="#Evidence26" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-6 and RACGAP1 form the heterotetrameric complex centralspindlin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction160">
 <bp:evidence rdf:resource="#Evidence181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABHD6,12 hydrolyse 3AG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction24">
 <bp:evidence rdf:resource="#Evidence27" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-14 is a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction25">
 <bp:evidence rdf:resource="#Evidence28" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZFPM proteins bind GATA proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction20">
 <bp:evidence rdf:resource="#Evidence23" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesins bind microtubules</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction21">
 <bp:evidence rdf:resource="#Evidence24" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-2 is a heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction167">
 <bp:evidence rdf:resource="#Evidence189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">urokinase plasminogen activator (one-chain):uPAR -&gt; urokinase plasminogen activator (two-chain):uPAR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction168">
 <bp:evidence rdf:resource="#Evidence190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">crosslinked fibrin multimer:tissue plasminogen activator (one-chain):plasminogen -&gt; crosslinked fibrin multimer:tissue plasminogen activator (one-chain) + plasmin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction165">
 <bp:evidence rdf:resource="#Evidence187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">crosslinked fibrin multimer + tissue plasminogen activator (one-chain) -&gt; crosslinked fibrin multimer:tissue plasminogen activator (one-chain)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction166">
 <bp:evidence rdf:resource="#Evidence188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLG(20-810) binds aprotinin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction26">
 <bp:evidence rdf:resource="#Evidence29" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rabenosyn-5 connects  Rab5 to VPS-45</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction163">
 <bp:evidence rdf:resource="#Evidence185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">urokinase plasminogen activator (two-chain):uPAR + plasminogen activator inhibitor 1 (PAI-1) -&gt; PAI-1:urokinase plasminogen activator (two-chain):uPAR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction27">
 <bp:evidence rdf:resource="#Evidence30" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF1 binds the promoters of Interferon alpha and beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction164">
 <bp:evidence rdf:resource="#Evidence186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">plasminogen + histidine-rich glycoprotein -&gt; plasminogen:histidine-rich glycoprotein</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction28">
 <bp:evidence rdf:resource="#Evidence31" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC16A binds F-actin capping protein</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction161">
 <bp:evidence rdf:resource="#Evidence182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG is metabolized by DAGL to 2-AG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction29">
 <bp:evidence rdf:resource="#Evidence32" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">F-actin capping protein is a heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction162">
 <bp:evidence rdf:resource="#Evidence183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Protein Kinase C novel isoforms</bp:displayName>
</bp:BiochemicalReaction>

<bp:BioSource rdf:ID="BioSource1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homo sapiens</bp:name>
</bp:BioSource>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction11">
 <bp:evidence rdf:resource="#Evidence14" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-7 is a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction170">
 <bp:evidence rdf:resource="#Evidence192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">crosslinked fibrin multimer:tissue plasminogen activator (two-chain):plasminogen -&gt; crosslinked fibrin multimer:tissue plasminogen activator (two-chain) + plasmin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction12">
 <bp:evidence rdf:resource="#Evidence15" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-12 is a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction171">
 <bp:evidence rdf:resource="#Evidence193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">crosslinked fibrin multimer:tissue plasminogen activator (one-chain) -&gt; crosslinked fibrin multimer:tissue plasminogen activator (two-chain)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction13">
 <bp:evidence rdf:resource="#Evidence16" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-13 is a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction14">
 <bp:evidence rdf:resource="#Evidence17" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-1 is a heterotetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction10">
 <bp:evidence rdf:resource="#Evidence12" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITPK1 converts Ins-3,4,5,6-P4 to Ins-1,3,4,5,6-P5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction19">
 <bp:evidence rdf:resource="#Evidence22" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-8 is a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction178">
 <bp:evidence rdf:resource="#Evidence200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">crosslinked fibrin multimer:tissue plasminogen activator (two-chain) + plasminogen -&gt; crosslinked fibrin multimer:tissue plasminogen activator (two-chain):plasminogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction179">
 <bp:evidence rdf:resource="#Evidence201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLG(20-810) binds anti-fibrinolytics</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction176">
 <bp:evidence rdf:resource="#Evidence198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">fibrin multimer, crosslinked -&gt; fibrin digestion products (plasmin)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction177">
 <bp:evidence rdf:resource="#Evidence199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">fibrin multimer, crosslinked:tissue plasminogen activator (one-chain) + plasminogen activator inhibitor 1 -&gt; fibrin multimer, crosslinked:tissue plasminogen activator (one-chain):plasminogen activator inhibitor 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction15">
 <bp:evidence rdf:resource="#Evidence18" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesins move along microtubules consuming ATP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction174">
 <bp:evidence rdf:resource="#Evidence196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">alpha-2-antiplasmin + plasmin -&gt; alpha-2-antiplasmin:plasmin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction16">
 <bp:evidence rdf:resource="#Evidence19" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-3 is a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction175">
 <bp:evidence rdf:resource="#Evidence197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">urokinase plasminogen activator + urokinase plasminogen activator receptor (uPAR) -&gt; urokinase plasminogen activator:uPAR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction17">
 <bp:evidence rdf:resource="#Evidence20" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesin-5 is a homotetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction172">
 <bp:evidence rdf:resource="#Evidence194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">fibrin multimer, crosslinked:tissue plasminogen activator (two-chain) + plasminogen activator inhibitor 1 -&gt; fibrin multimer, crosslinked:tissue plasminogen activator (two-chain):plasminogen activator inhibitor 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction18">
 <bp:evidence rdf:resource="#Evidence21" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chromokinesins form dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction173">
 <bp:evidence rdf:resource="#Evidence195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">plasminogen:histidine-rich glycoprotein -&gt; plasmin + histidine-rich glycoprotein (uPA [two-chain] catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction181">
 <bp:evidence rdf:resource="#Evidence203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">histidine-rich glycoprotein:plasminogen &lt;-&gt; histidine-rich glycoprotein + plasminogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction182">
 <bp:evidence rdf:resource="#Evidence204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">crosslinked fibrin multimer:tissue plasminogen activator (one-chain) + plasminogen -&gt; crosslinked fibrin multimer:tissue plasminogen activator (one-chain):plasminogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction180">
 <bp:evidence rdf:resource="#Evidence202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">plasminogen:histidine-rich glycoprotein -&gt; plasmin + histidine-rich glycoprotein (uPA [one-chain] catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction189">
 <bp:evidence rdf:resource="#Evidence212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADAMTS13 cleaves VWF multimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction187">
 <bp:evidence rdf:resource="#Evidence210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of GPVI and FceRI gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction188">
 <bp:evidence rdf:resource="#Evidence211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Collagen type I binds integrin alpha1beta1, alpha2beta1, alpha10beta1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction185">
 <bp:evidence rdf:resource="#Evidence208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPIb:IX:V binds to VWF multimer:collagen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction186">
 <bp:evidence rdf:resource="#Evidence209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caplacizumab binds VWF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction183">
 <bp:evidence rdf:resource="#Evidence205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">histidine-rich glycoprotein + plasminogen &lt;-&gt; histidine-rich glycoprotein:plasminogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction184">
 <bp:evidence rdf:resource="#Evidence207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VWF multimer binds to collagen type I</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction118">
 <bp:evidence rdf:resource="#Evidence135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction119">
 <bp:evidence rdf:resource="#Evidence136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of inactive SRC by PTPB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction116">
 <bp:evidence rdf:resource="#Evidence133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of pPTK2 by SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction117">
 <bp:evidence rdf:resource="#Evidence134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Clustering of Integrin alphaIIb beta3 complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction114">
 <bp:evidence rdf:resource="#Evidence131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of RIAM to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction115">
 <bp:evidence rdf:resource="#Evidence132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of CSK from SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence30">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence31">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence32">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence33">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence34">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence35">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction112">
 <bp:evidence rdf:resource="#Evidence129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK activation by SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence36">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction113">
 <bp:evidence rdf:resource="#Evidence130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alpha IIb beta3 T779 phosphorylation blocks SHC binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence37">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction110">
 <bp:evidence rdf:resource="#Evidence127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated integrin alphaIIb beta3 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence38">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction111">
 <bp:evidence rdf:resource="#Evidence128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 bound to integrin alphaIIb beta3 is phosphorylated somehow</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence39">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction129">
 <bp:evidence rdf:resource="#Evidence148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of Syk tyrosine kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction127">
 <bp:evidence rdf:resource="#Evidence145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PTK2 at Y397</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction128">
 <bp:evidence rdf:resource="#Evidence146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin binding to GP1b:IX:V</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction125">
 <bp:evidence rdf:resource="#Evidence143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Rap1 by cytosolic GEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction126">
 <bp:evidence rdf:resource="#Evidence144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alphaIIb beta3 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis9">
 <bp:controlled rdf:resource="#BiochemicalReaction58" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis8">
 <bp:controlled rdf:resource="#BiochemicalReaction57" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis7">
 <bp:controlled rdf:resource="#BiochemicalReaction55" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis6">
 <bp:controlled rdf:resource="#BiochemicalReaction35" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis5">
 <bp:controlled rdf:resource="#BiochemicalReaction10" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis4">
 <bp:controlled rdf:resource="#BiochemicalReaction9" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis3">
 <bp:controlled rdf:resource="#BiochemicalReaction7" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis2">
 <bp:controlled rdf:resource="#BiochemicalReaction6" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis1">
 <bp:controlled rdf:resource="#BiochemicalReaction1" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence20">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence21">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence22">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence23">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence24">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction123">
 <bp:evidence rdf:resource="#Evidence141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2 to p-PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence25">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction124">
 <bp:evidence rdf:resource="#Evidence142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of SOS with GRB2 bound to FADK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence26">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction121">
 <bp:evidence rdf:resource="#Evidence138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Talin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence27">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction122">
 <bp:evidence rdf:resource="#Evidence139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PTK2 to Focal complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence28">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence29">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction120">
 <bp:evidence rdf:resource="#Evidence137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Rap1 by membrane-associated GEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction138">
 <bp:evidence rdf:resource="#Evidence157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unknown kinase phosphorylates CLEC1B dimer:PDPN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction139">
 <bp:evidence rdf:resource="#Evidence158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Syk/Lck phosphorylate LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction136">
 <bp:evidence rdf:resource="#Evidence155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Syk activation leads to SLP-76 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction137">
 <bp:evidence rdf:resource="#Evidence156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP2 binds inhibiting VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence50">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence51">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence299">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence52">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence53">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence297">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence54">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence298">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence55">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence295">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence56">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence296">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence57">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction134">
 <bp:evidence rdf:resource="#Evidence153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 activates PRKCZ</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence293">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence58">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction135">
 <bp:evidence rdf:resource="#Evidence154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 binds PRKCZ</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence294">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence59">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction132">
 <bp:evidence rdf:resource="#Evidence151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI(3,4,5)P3 binds VAV1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence291">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction133">
 <bp:evidence rdf:resource="#Evidence152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VAV3 is a GEF for Rho/Rac family kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence292">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction130">
 <bp:evidence rdf:resource="#Evidence149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC gamma 2-mediated PIP2 hydrolysis</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction131">
 <bp:evidence rdf:resource="#Evidence150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-SLP-76 binds VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence290">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction149">
 <bp:evidence rdf:resource="#Evidence168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VAV2 is a GEF for Rho/Rac family kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction147">
 <bp:evidence rdf:resource="#Evidence166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 recruits PDPK1 to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction148">
 <bp:evidence rdf:resource="#Evidence167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC1B dimer binds PDPN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence40">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence288">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence41">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence289">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence42">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence286">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence43">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence287">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence44">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence284">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence45">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence285">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence46">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction145">
 <bp:evidence rdf:resource="#Evidence164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y348-SYK binds VAV family</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence47">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction146">
 <bp:evidence rdf:resource="#Evidence165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K alpha, beta, gamma convert PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence48">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction143">
 <bp:evidence rdf:resource="#Evidence162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VAV1 is a GEF for Rho/Rac family GTPases</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence280">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence49">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction144">
 <bp:evidence rdf:resource="#Evidence163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fyn/Lyn-mediated phosphorylation of FcR1 gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence281">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction141">
 <bp:evidence rdf:resource="#Evidence160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y7-CLEC1B dimer:PDPN binds SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction142">
 <bp:evidence rdf:resource="#Evidence161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G6B binds PTPN6,PTPN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction140">
 <bp:evidence rdf:resource="#Evidence159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep181">
 <bp:stepProcess rdf:resource="#Catalysis45" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction161" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction318">
 <bp:evidence rdf:resource="#Evidence356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor XI:platelet glycoprotein (GP) Ib:IX:V complex -&gt; factor XIa:platelet glycoprotein (GP) Ib:IX:V complex (XIIa catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction160" />
 <bp:stepProcess rdf:resource="#Catalysis44" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction319">
 <bp:evidence rdf:resource="#Evidence357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor IX -&gt; factor IXa + factor IX activation peptide (factor XIa catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction316">
 <bp:evidence rdf:resource="#Evidence354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor VIII:von Willibrand factor multimer -&gt; factor VIIIa + factor VIIIa B A3 acidic polypeptide + von Willibrand factor multimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction317">
 <bp:evidence rdf:resource="#Evidence355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">kallikrein binds SERPING1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep185">
 <bp:stepProcess rdf:resource="#BiochemicalReaction164" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction314">
 <bp:evidence rdf:resource="#Evidence352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor IXa associates with cell membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep184">
 <bp:stepProcess rdf:resource="#Catalysis46" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction163" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction315">
 <bp:evidence rdf:resource="#Evidence353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SERPING1 is secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep183">
 <bp:stepProcess rdf:resource="#Pathway22" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction312">
 <bp:evidence rdf:resource="#Evidence350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor XIIa binds SERPING1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction162" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction313">
 <bp:evidence rdf:resource="#Evidence351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor IIa inhibitors (compounds) binds IIa</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction168" />
 <bp:stepProcess rdf:resource="#Catalysis48" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction167" />
 <bp:stepProcess rdf:resource="#Catalysis47" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction166" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep186">
 <bp:stepProcess rdf:resource="#BiochemicalReaction165" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence70">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence71">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence72">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence73">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence74">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence278">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence75">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence275">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence76">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence77">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence78">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence79">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence271">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction310">
 <bp:evidence rdf:resource="#Evidence348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor VIIIa associates with cell membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence272">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction311">
 <bp:evidence rdf:resource="#Evidence349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor X -&gt; factor Xa + factor X activation peptide (VIIIa:IXa catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence270">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction171" />
 <bp:stepProcess rdf:resource="#Catalysis51" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction329">
 <bp:evidence rdf:resource="#Evidence368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated protein C binds Protein S</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep191">
 <bp:stepProcess rdf:resource="#BiochemicalReaction170" />
 <bp:stepProcess rdf:resource="#Catalysis50" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction169" />
 <bp:stepProcess rdf:resource="#Catalysis49" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction327">
 <bp:evidence rdf:resource="#Evidence366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor Xa inhibitors binds Xa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction328">
 <bp:evidence rdf:resource="#Evidence367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated protein C cleaves factor VIIIa</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction175" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction325">
 <bp:evidence rdf:resource="#Evidence364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">thrombin:cleaved SERPINC1:SERPINC1 activators -&gt; thrombin:cleaved SERPINC1 + SERPINC1 activators</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep195">
 <bp:stepProcess rdf:resource="#Catalysis54" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction174" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction326">
 <bp:evidence rdf:resource="#Evidence365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor Va + factor Xa -&gt; Va:Xa complex (prothrombinase)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep194">
 <bp:stepProcess rdf:resource="#Catalysis53" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction173" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction323">
 <bp:evidence rdf:resource="#Evidence362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated protein C:PROCR binds F2R</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep193">
 <bp:stepProcess rdf:resource="#Catalysis52" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction172" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction324">
 <bp:evidence rdf:resource="#Evidence363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Soluble PROCR binds PRTN3:CD177</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep199">
 <bp:stepProcess rdf:resource="#BiochemicalReaction178" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep198">
 <bp:stepProcess rdf:resource="#Catalysis56" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction177" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep197">
 <bp:stepProcess rdf:resource="#Catalysis55" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction176" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence259">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence60">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence61">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence62">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence63">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence64">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence264">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence65">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence66">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence67">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence68">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence260">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction321">
 <bp:evidence rdf:resource="#Evidence360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SERPINC1 binds SERPINC1 activators</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence69">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence261">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction322">
 <bp:evidence rdf:resource="#Evidence361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">thrombin:antithrombin III:heparin -&gt; thrombin:cleaved antithrombin III:heparin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction320">
 <bp:evidence rdf:resource="#Evidence359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Soluble PROCR binds activated protein C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction338">
 <bp:evidence rdf:resource="#Evidence377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">n fibrin monomers -&gt; fibrin multimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction339">
 <bp:evidence rdf:resource="#Evidence378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">fibrinogen -&gt; fibrin monomer + 2 fibrinopeptide A + 2 fibrinopeptide B</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction145" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction336">
 <bp:evidence rdf:resource="#Evidence375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated protein C is released from PROCR</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction144" />
 <bp:stepProcess rdf:resource="#Catalysis37" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction337">
 <bp:evidence rdf:resource="#Evidence376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated protein C cleaves factor Va to factor Vi intermediate form</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep161">
 <bp:stepProcess rdf:resource="#Catalysis36" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction143" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction334">
 <bp:evidence rdf:resource="#Evidence373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor Xa inhibitors bind Va:Xa</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction142" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction335">
 <bp:evidence rdf:resource="#Evidence374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">prothrombin -&gt; activated thrombin (factor IIa) + thrombin activation peptide (Xa catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep167">
 <bp:stepProcess rdf:resource="#BiochemicalReaction149" />
 <bp:stepProcess rdf:resource="#Catalysis39" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep166">
 <bp:stepProcess rdf:resource="#BiochemicalReaction148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction146" />
 <bp:stepProcess rdf:resource="#Catalysis38" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence90">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence91">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction151" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence248">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence92">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep168">
 <bp:stepProcess rdf:resource="#Catalysis40" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction150" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence93">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction99">
 <bp:evidence rdf:resource="#Evidence112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">F2R:ARRB2 binds MAPKs, SRC-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence94">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence258">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence95">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence255">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence96">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence256">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence97">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction95">
 <bp:evidence rdf:resource="#Evidence108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin-activated PARs:Gq (active) dissociate</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence253">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence98">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction96">
 <bp:evidence rdf:resource="#Evidence109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin-activated PARs binds G-protein G12/13</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence99">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction97">
 <bp:evidence rdf:resource="#Evidence110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC-1 is activated (in F2R:ARRB1:MAPKs:SRC-1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence251">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction98">
 <bp:evidence rdf:resource="#Evidence111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated thrombin (factor IIa) cleaves PAR3,4, activating them</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence252">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction332">
 <bp:evidence rdf:resource="#Evidence371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PROCR binds Protein C</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence250">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction333">
 <bp:evidence rdf:resource="#Evidence372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor V -&gt; factor Va + factor V activation peptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction330">
 <bp:evidence rdf:resource="#Evidence369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated protein C cleaves Factor Va intermediate form for Factor Va</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction331">
 <bp:evidence rdf:resource="#Evidence370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Heparin cofactor 2 (SERPIND1) binds activated thrombin (factor IIa)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction109">
 <bp:evidence rdf:resource="#Evidence126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds to integrin alphaIIb beta3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction152" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction107">
 <bp:evidence rdf:resource="#Evidence124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of BCAR1 to PTK2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction108">
 <bp:evidence rdf:resource="#Evidence125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of BCAR1 by SRC-PTK2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction105">
 <bp:evidence rdf:resource="#Evidence121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 dissociates from integrin alphaIIb beta3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction155" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction347">
 <bp:evidence rdf:resource="#Evidence386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">prothrombin -&gt; activated thrombin (factor IIa) + thrombin activation peptide (prothrombinase catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction106">
 <bp:evidence rdf:resource="#Evidence123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Crk binding to p130cas</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep173">
 <bp:stepProcess rdf:resource="#Catalysis41" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction154" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction348">
 <bp:evidence rdf:resource="#Evidence387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SERPINA5 binds activated protein C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction103">
 <bp:evidence rdf:resource="#Evidence118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRA2A,B,C bind ADR,NAd</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep172">
 <bp:stepProcess rdf:resource="#Pathway20" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction345">
 <bp:evidence rdf:resource="#Evidence384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated thrombin (factor IIa) + antithrombin III:heparin -&gt; thrombin:antithrombin III:heparin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction104">
 <bp:evidence rdf:resource="#Evidence120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of integrin alphaIIb beta3 with Fibrinogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction153" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction346">
 <bp:evidence rdf:resource="#Evidence385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protease nexin-1 (PN1) is a specific and extremely efficient inhibitor of thrombin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction91">
 <bp:evidence rdf:resource="#Evidence104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-F2R binds vorapaxar</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep178">
 <bp:stepProcess rdf:resource="#Pathway21" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction92">
 <bp:evidence rdf:resource="#Evidence105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated SRC-1 activates MAPKs (in F2R:ARRB1:MAPKs:active SRC-1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep177">
 <bp:stepProcess rdf:resource="#Catalysis42" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction158" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction93">
 <bp:evidence rdf:resource="#Evidence106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated thrombin (factor IIa) cleaves F2R (PAR1), activating it</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction157" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction94">
 <bp:evidence rdf:resource="#Evidence107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">F2R binds ARRB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction156" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence80">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence237">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence81">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction90">
 <bp:evidence rdf:resource="#Evidence103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin-activated PARs activate G12/13</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep179">
 <bp:stepProcess rdf:resource="#Catalysis43" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction159" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence238">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence82">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction88">
 <bp:evidence rdf:resource="#Evidence101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">F2R:ARRB1 binds MAPKs, SRC-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence83">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction89">
 <bp:evidence rdf:resource="#Evidence102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">F2R binds ARRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence84">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence244">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence85">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence86">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction84">
 <bp:evidence rdf:resource="#Evidence96" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABCC4 accumulation of dense granule contents</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence242">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence87">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction85">
 <bp:evidence rdf:resource="#Evidence97" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of (inferred) platelet cytosolic components</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence88">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction86">
 <bp:evidence rdf:resource="#Evidence99" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin-activated PARs activate Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence89">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction87">
 <bp:evidence rdf:resource="#Evidence100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC-1 bound to ARRB2 is not activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence241">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction101">
 <bp:evidence rdf:resource="#Evidence114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin-activated PARs binds G-protein Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction343">
 <bp:evidence rdf:resource="#Evidence382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated thrombin (factor IIa) + thrombomodulin -&gt; activated thrombin:thrombomodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction102">
 <bp:evidence rdf:resource="#Evidence116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombopoietin binds the thrombopoietin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction344">
 <bp:evidence rdf:resource="#Evidence383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor XIII -&gt; factor XIII cleaved tetramer + 2 factor XIII A activation peptides</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction341">
 <bp:evidence rdf:resource="#Evidence380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">fibrin multimer -&gt; fibrin multimer, crosslinked + NH4+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction100">
 <bp:evidence rdf:resource="#Evidence113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin-activated PARs:G12/13 (active) dissociate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction342">
 <bp:evidence rdf:resource="#Evidence381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated thrombin:thrombomodulin cleaves PROCR:Protein C to PROCR:Activated protein C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction340">
 <bp:evidence rdf:resource="#Evidence379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">factor XIII cleaved tetramer + 2 Ca++ -&gt; factor XIIIa + 2 factor XIII B chain</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction344" />
 <bp:stepProcess rdf:resource="#Catalysis101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction343" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction342" />
 <bp:stepProcess rdf:resource="#Catalysis100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep145">
 <bp:stepProcess rdf:resource="#BiochemicalReaction128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction127" />
 <bp:stepProcess rdf:resource="#Catalysis29" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep386">
 <bp:stepProcess rdf:resource="#BiochemicalReaction348" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep385">
 <bp:stepProcess rdf:resource="#BiochemicalReaction347" />
 <bp:stepProcess rdf:resource="#Catalysis102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction125" />
 <bp:stepProcess rdf:resource="#Catalysis28" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction346" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep148">
 <bp:stepProcess rdf:resource="#Catalysis30" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction130" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep146">
 <bp:stepProcess rdf:resource="#Pathway19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep139">
 <bp:stepProcess rdf:resource="#Pathway18" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway9">
 <bp:pathwayOrder rdf:resource="#PathwayStep79" />
 <bp:pathwayOrder rdf:resource="#PathwayStep78" />
 <bp:pathwayOrder rdf:resource="#PathwayStep73" />
 <bp:pathwayOrder rdf:resource="#PathwayStep72" />
 <bp:pathwayOrder rdf:resource="#PathwayStep77" />
 <bp:pathwayOrder rdf:resource="#PathwayStep76" />
 <bp:pathwayOrder rdf:resource="#PathwayStep75" />
 <bp:pathwayOrder rdf:resource="#PathwayStep74" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction66" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction67" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction68" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction69" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction65" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction70" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction71" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence72" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thromboxane signalling through TP receptor</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thromboxane (TXA2) binds to the thromboxane receptor (TP). There are 2 splice variant forms of TP, differing in their cytoplasmic carboxyl terminal tails. TP beta was first identified in endothelial cells. TP alpha was identified in platelets and placenta. The major signalling route for TP is Gq-mediated stimulation of PLC and consequent increase in cellular calcium. TP also couples to G13, leading to stimulation of Rho and Rac.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway7">
 <bp:pathwayOrder rdf:resource="#PathwayStep59" />
 <bp:pathwayOrder rdf:resource="#PathwayStep62" />
 <bp:pathwayOrder rdf:resource="#PathwayStep61" />
 <bp:pathwayOrder rdf:resource="#PathwayStep60" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction55" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction56" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction54" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence59" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADP signalling through P2Y purinoceptor 12</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-activation of P2Y1 and P2Y12 is necessary for complete platelet activation. P2Y1 is coupled to Gq and helps trigger the release of calcium from internal stores, leading to weak and reversible platelet aggregation. P2Y12 is Gi coupled, inhibiting adenylate cyclase, leading to decreased cAMP, a consequent decrease in cAMP-dependent protein kinase activity which increases cytoplasmic [Ca2+], necessary for activation (Woulfe et al. 2001).   In activated platelets, P2Y12 signaling is required for the amplification of aggregation induced by all platelet agonists including collagen, thrombin, thromboxane, adrenaline and serotonin. P2Y12 activation causes potentiation of thromboxane generation, secretion leading to irreversible platelet aggregation and thrombus stabilization. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway8">
 <bp:pathwayOrder rdf:resource="#PathwayStep69" />
 <bp:pathwayOrder rdf:resource="#PathwayStep68" />
 <bp:pathwayOrder rdf:resource="#PathwayStep67" />
 <bp:pathwayOrder rdf:resource="#PathwayStep70" />
 <bp:pathwayOrder rdf:resource="#PathwayStep66" />
 <bp:pathwayOrder rdf:resource="#PathwayStep65" />
 <bp:pathwayOrder rdf:resource="#PathwayStep64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction57" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction58" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction62" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction63" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction60" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction61" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction59" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence64" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADP signalling through P2Y purinoceptor 1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-activation of P2Y1 and P2Y12 is necessary for complete platelet activation. P2Y1 is coupled to Gq and helps trigger the release of calcium from internal stores, leading to weak and reversible platelet aggregation. P2Y12 is Gi coupled, inhibiting adenylate cyclase, leading to decreased cAMP, a consequent decrease in cAMP-dependent protein kinase activity which increases cytoplasmic [Ca2+], necessary for activation (Woulfe et al. 2001).   In activated platelets, P2Y12 signaling is required for the amplification of aggregation induced by all platelet agonists including collagen, thrombin, thromboxane, adrenaline and serotonin. P2Y12 activation causes potentiation of thromboxane generation, secretion leading to irreversible platelet aggregation and thrombus stabilization. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway5">
 <bp:pathwayOrder rdf:resource="#PathwayStep48" />
 <bp:pathwayOrder rdf:resource="#PathwayStep56" />
 <bp:pathwayOrder rdf:resource="#PathwayStep49" />
 <bp:pathwayOrder rdf:resource="#PathwayStep51" />
 <bp:pathwayOrder rdf:resource="#PathwayStep50" />
 <bp:pathwayOrder rdf:resource="#PathwayStep55" />
 <bp:pathwayOrder rdf:resource="#PathwayStep54" />
 <bp:pathwayOrder rdf:resource="#PathwayStep53" />
 <bp:pathwayOrder rdf:resource="#PathwayStep52" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction44" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction45" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction46" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction47" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction51" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction52" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction50" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction48" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction49" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence48" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GP1b-IX-V activation signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The platelet GPIb complex (GP1b-IX-V) together with GPVI are primarily responsible for regulating the initial adhesion of platelets to the damaged blood vessel and platelet activation. The importance of GPIb is demonstrated by the bleeding problems in patients with Bernard-Soulier syndrome where this receptor is either absent or defective. GP1b-IX-V binds von Willebrand Factor (vWF) to resting platelets, particularly under conditions of high shear stress. This transient interaction is the first stage of the vascular repair process. Activation of GP1b-IX-V on exposure of the fibrous matrix following atherosclerotic plaque rupture, or in occluded arteries, is a major contributory factor leading to thrombus formation leading to heart attack or stroke. GpIb also binds thrombin (Yamamoto et al. 1986), at a site distinct from the site of vWF binding, acting as a docking site for thrombin which then activates Proteinase Activated Receptors leading to enhanced platelet activation (Dormann et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep152">
 <bp:stepProcess rdf:resource="#Catalysis32" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction134" />
</bp:PathwayStep>

<bp:Provenance rdf:ID="Provenance1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reactome</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.reactome.org</bp:comment>
</bp:Provenance>

<bp:Pathway rdf:ID="Pathway6">
 <bp:pathwayOrder rdf:resource="#PathwayStep58" />
 <bp:pathwayOrder rdf:resource="#PathwayStep71" />
 <bp:pathwayOrder rdf:resource="#PathwayStep63" />
 <bp:pathwayComponent rdf:resource="#Pathway9" />
 <bp:pathwayComponent rdf:resource="#Pathway7" />
 <bp:pathwayComponent rdf:resource="#Pathway8" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence58" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signal amplification</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the initial response to injury, platelets adhere to damaged blood vessels, responding to the exposure of collagen from the vascular epithelium. Once adhered they degranulate, releasing stored secondary agents such as ADP and ATP, and synthesized thromboxane A2. These amplify the response, activating and recruiting further platelets to the area and promoting platelet aggregation. Adenosine nucleotides secreted following platelet activation signal through P2 purinergic receptors on the platelet membrane. ADP activates P2Y1 and P2Y12 while ATP activates the ionotropic P2X1 receptor (Kunapuli et al. 2003). Activation of these receptors initiates a complex signaling cascade that ultimately results in platelet activation and thrombus formation (Kahner et al. 2006). ADP stimulation of P2Y1 and P2Y12 involves signaling via both the alpha and gamma:beta components of the heterotrimeric G-protein (Hirsch et al. 2001, 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep151">
 <bp:stepProcess rdf:resource="#Catalysis31" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction133" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway3">
 <bp:pathwayOrder rdf:resource="#PathwayStep15" />
 <bp:pathwayOrder rdf:resource="#PathwayStep26" />
 <bp:pathwayOrder rdf:resource="#PathwayStep14" />
 <bp:pathwayOrder rdf:resource="#PathwayStep25" />
 <bp:pathwayOrder rdf:resource="#PathwayStep13" />
 <bp:pathwayOrder rdf:resource="#PathwayStep24" />
 <bp:pathwayOrder rdf:resource="#PathwayStep23" />
 <bp:pathwayOrder rdf:resource="#PathwayStep19" />
 <bp:pathwayOrder rdf:resource="#PathwayStep18" />
 <bp:pathwayOrder rdf:resource="#PathwayStep17" />
 <bp:pathwayOrder rdf:resource="#PathwayStep16" />
 <bp:pathwayOrder rdf:resource="#PathwayStep22" />
 <bp:pathwayOrder rdf:resource="#PathwayStep21" />
 <bp:pathwayOrder rdf:resource="#PathwayStep20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction11" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction22" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction12" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction23" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction13" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction24" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction14" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction19" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction15" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction16" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction17" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction18" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence13" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinesins are a superfamily of  microtubule-based motor proteins that have diverse functions in transport of vesicles, organelles and chromosomes, and regulate microtubule dynamics. There are 14 families of kinesins, all reprsented in humans. A standardized nomenclature was published in 2004 (Lawrence et al.).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction132" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway4">
 <bp:pathwayOrder rdf:resource="#PathwayStep47" />
 <bp:pathwayOrder rdf:resource="#PathwayStep57" />
 <bp:pathwayOrder rdf:resource="#PathwayStep80" />
 <bp:pathwayOrder rdf:resource="#PathwayStep172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep97" />
 <bp:pathwayOrder rdf:resource="#PathwayStep114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep146" />
 <bp:pathwayComponent rdf:resource="#Pathway5" />
 <bp:pathwayComponent rdf:resource="#Pathway19" />
 <bp:pathwayComponent rdf:resource="#Pathway6" />
 <bp:pathwayComponent rdf:resource="#Pathway14" />
 <bp:pathwayComponent rdf:resource="#Pathway13" />
 <bp:pathwayComponent rdf:resource="#Pathway10" />
 <bp:pathwayComponent rdf:resource="#Pathway20" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence47" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet activation, signaling and aggregation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet activation begins with the initial binding of adhesive ligands and of the excitatory platelet agonists (released or generated at the sites of vascular trauma) to cognate receptors on the platelet membrane (Ruggeri 2002). Intracellular signaling reactions then enhance the adhesive and procoagulant properties of tethered platelets or of platelets circulating in the proximity. Once platelets have adhered they degranulate, releasing stored secondary agents such as ADP, ATP, and synthesize thromboxane A2. These amplify the response, activating and recruiting further platelets to the area and promoting platelet aggregation. These amplify the response, activating and recruiting further platelets to the area and promoting platelet aggregation. Adenosine nucleotides signal through P2 purinergic receptors on the platelet membrane. ADP activates P2Y1 and P2Y12, which signal via  both the alpha and gamma:beta components of the heterotrimeric G-protein (Hirsch et al. 2001, 2006), while ATP activates the ionotropic P2X1 receptor (Kunapuli et al. 2003). Activation of these receptors initiates a complex signaling cascade that ultimately results in platelet activation, aggregation and thrombus formation (Kahner et al. 2006). Integrin AlphaIIbBeta3 is the most abundant platelet receptor, with 40 000 to 80 000 copies per resting platelet, acting as a major receptor for fibrinogen and other adhesive molecules (Wagner et al. 1996). Activation of AlphaIIbBeta3 enhances adhesion and leads to platelet-platelet interactions, and thus aggregation (Philips et al. 1991). GP VI is the most potent collagen receptor initiating signal generation, an ability derived from its interaction with the FcRI gamma chain. This results in the phosphorylation of the gamma-chain by non-receptor tyrosine kinases of the Src family (1). The phosphotyrosine motif is recognized by the SH2 domains of Syk, a tyrosine kinase. This association activates the Syk enzyme, leading to activation (by tyrosine phosphorylation) of PLC gamma2 (2). Thrombin is an important platelet agonist generated on the membrane of stimulated platelets. Thrombin acts via cell surface Protease Activated Receptors (PARs). PARs are G-protein coupled receptors activated by a proteolytic cleavage in an extracellular loop (Vu, 1991) (3). Activated PARs signal via G alpha q (4) and via the beta:gamma component of the G-protein (5). Both stimulate PLC giving rise to PIP2 hydrolysis and consequent activation of PI3K (6). PLCgamma2 activation also gives rise to IP3 (7) which stimulates the IP3 receptor (8) leading to increased intracellular calcium. Platelet activation further results in the scramblase-mediated transport of negatively-charged phospholipids to the platelet surface. These phospholipids provide a catalytic surface (with the charge provided by phosphatidylserine and phosphatidylethanolamine) for the tenase complex (formed by the activated forms of the blood coagulation factors factor VIII and factor I).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway1">
 <bp:pathwayOrder rdf:resource="#PathwayStep1" />
 <bp:pathwayOrder rdf:resource="#PathwayStep46" />
 <bp:pathwayOrder rdf:resource="#PathwayStep205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep214" />
 <bp:pathwayOrder rdf:resource="#PathwayStep322" />
 <bp:pathwayComponent rdf:resource="#Pathway4" />
 <bp:pathwayComponent rdf:resource="#Pathway2" />
 <bp:pathwayComponent rdf:resource="#Pathway36" />
 <bp:pathwayComponent rdf:resource="#Pathway24" />
 <bp:pathwayComponent rdf:resource="#Pathway23" />
 <bp:pathwayComponent rdf:resource="#Pathway22" />
 <bp:pathwayComponent rdf:resource="#Pathway32" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hemostasis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hemostasis is a physiological response that culminates in the arrest of bleeding from an injured vessel. Under normal conditions the vascular endothelium supports vasodilation, inhibits platelet adhesion and activation, suppresses coagulation, enhances fibrin cleavage and is anti-inflammatory in character. Under acute vascular trauma, vasoconstrictor mechanisms predominate and the endothelium becomes prothrombotic, procoagulatory and proinflammatory in nature. This is achieved by a reduction of endothelial dilating agents: adenosine, NO and prostacyclin; and by the direct action of ADP, serotonin and thromboxane on vascular smooth muscle cells to elicit their contraction (Becker et al. 2000).  The chief trigger for the change in endothelial function that leads to the formation of a haemostatic thrombus is the loss of the endothelial cell barrier between blood and extracellular matrix components (Ruggeri 2002). Circulating platelets identify and discriminate areas of endothelial lesions; here, they adhere to the exposed sub endothelium. Their interaction with the various thrombogenic substrates and locally generated or released agonists results in platelet activation. This process is described as possessing two stages, firstly, adhesion -  the initial tethering to a surface, and secondly aggregation - the platelet-platelet cohesion (Savage    Cattaneo et al. 2001). Three mechansism contribute to the loss of blood following vessel injury. The vessel constricts, reducing the loss of blood. Platelets adhere to the site of injury, become activated and aggregate with fibrinogen into a soft plug that limits blood loss, a process termed primary hemostasis. Proteins and small molecules are released from granules by activated platelets,  stimulating the plug formation process. Fibrinogen from plasma forms bridges between activated platelets. These events initiate the clotting cascade (secondary hemostasis). Negatively-charged phospholipids exposed at the site of injury and on activated platelets interact with tissue factor, leading to a cascade of reactions that culminates with the formation of an insoluble fibrin clot.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep156">
 <bp:stepProcess rdf:resource="#BiochemicalReaction138" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway2">
 <bp:pathwayOrder rdf:resource="#PathwayStep2" />
 <bp:pathwayOrder rdf:resource="#PathwayStep45" />
 <bp:pathwayOrder rdf:resource="#PathwayStep6" />
 <bp:pathwayOrder rdf:resource="#PathwayStep5" />
 <bp:pathwayOrder rdf:resource="#PathwayStep29" />
 <bp:pathwayOrder rdf:resource="#PathwayStep4" />
 <bp:pathwayOrder rdf:resource="#PathwayStep28" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3" />
 <bp:pathwayOrder rdf:resource="#PathwayStep27" />
 <bp:pathwayOrder rdf:resource="#PathwayStep40" />
 <bp:pathwayOrder rdf:resource="#PathwayStep44" />
 <bp:pathwayOrder rdf:resource="#PathwayStep43" />
 <bp:pathwayOrder rdf:resource="#PathwayStep42" />
 <bp:pathwayOrder rdf:resource="#PathwayStep41" />
 <bp:pathwayOrder rdf:resource="#PathwayStep9" />
 <bp:pathwayOrder rdf:resource="#PathwayStep8" />
 <bp:pathwayOrder rdf:resource="#PathwayStep7" />
 <bp:pathwayOrder rdf:resource="#PathwayStep37" />
 <bp:pathwayOrder rdf:resource="#PathwayStep36" />
 <bp:pathwayOrder rdf:resource="#PathwayStep35" />
 <bp:pathwayOrder rdf:resource="#PathwayStep12" />
 <bp:pathwayOrder rdf:resource="#PathwayStep34" />
 <bp:pathwayOrder rdf:resource="#PathwayStep39" />
 <bp:pathwayOrder rdf:resource="#PathwayStep38" />
 <bp:pathwayOrder rdf:resource="#PathwayStep11" />
 <bp:pathwayOrder rdf:resource="#PathwayStep33" />
 <bp:pathwayOrder rdf:resource="#PathwayStep10" />
 <bp:pathwayOrder rdf:resource="#PathwayStep32" />
 <bp:pathwayOrder rdf:resource="#PathwayStep31" />
 <bp:pathwayOrder rdf:resource="#PathwayStep30" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction9" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction8" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction7" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction6" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction5" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction4" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction33" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction34" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction36" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction30" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction31" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction10" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction32" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction3" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction37" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction38" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction39" />
 <bp:pathwayComponent rdf:resource="#Pathway3" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction25" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction40" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction41" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction42" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction43" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction26" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction27" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction28" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction29" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factors involved in megakaryocyte development and platelet production</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Megakaryocytes (MKs) give rise to circulating platelets (thrombocytes) through terminal differentiation of MKs which release cytoplasmic fragments as circulating platelets. As MKs mature they undergo endoreduplication (polyploidisation) and expansion of cytoplasmic mass to cell sizes larger than 50-100 microns, and ploidy ranges up to 128 N. As MKs mature, the polyploid nucleus becomes horseshoe-shaped, the cytoplasm expands, and platelet organelles and the demarcation membrane system are amplified. Proplatelet projections form which give rise to de novo circulating platelets (Deutsch    Tomer 2006).   The processes of megakaryocytopoiesis and platelet production occur within a complex microenvironment where chemokines, cytokines and adhesive interactions play major roles (Avecilla et al. 2004). Megakaryocytopoiesis is regulated at several levels including proliferation, differentiation and platelet release (Kaushansky 2003). Thrombopoietin (TPO/c-Mpl ligand) is the most potent cytokine stimulating proliferation and maturation of MK progenitors (Kaushansky 2005) but many other growth factors are involved. MK development is controlled by the action of multiple transcription factors. Many MK-specific genes are co-regulated by GATA and friend of GATA (FOG), RUNX1 and ETS proteins. Nuclear factor erythroid 2 (NF-E2), which has an MK-erythroid specific 45-kDa subunit, controls terminal MK maturation, proplatelet formation and platelet release (Schulze    Shivdasani 2004). NF-E2 deficient mice have profound thrombocytopenia (Shiraga et al. 1999). MYB (c-myb) functions with EP300 (p300) as a negative regulator of thrombopoiesis (Metcalf et al. 2005). During MK maturation, internal membrane systems, granules and organelles are assembled. Cytoplasmic fragmentation requires changes in the MK cytoskeleton and formation of organelles and channels. Individual organelles migrate from the cell body to the proplatelet ends, with approximately 30 percent of organelles/granules in motion at any given time (Richardson et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep155">
 <bp:stepProcess rdf:resource="#BiochemicalReaction137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep154">
 <bp:stepProcess rdf:resource="#BiochemicalReaction136" />
 <bp:stepProcess rdf:resource="#Catalysis33" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep159">
 <bp:stepProcess rdf:resource="#BiochemicalReaction141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep158">
 <bp:stepProcess rdf:resource="#Catalysis35" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep157">
 <bp:stepProcess rdf:resource="#BiochemicalReaction139" />
 <bp:stepProcess rdf:resource="#Catalysis34" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction322" />
 <bp:stepProcess rdf:resource="#Catalysis92" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction107" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep365">
 <bp:stepProcess rdf:resource="#BiochemicalReaction327" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep121">
 <bp:stepProcess rdf:resource="#Pathway17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep362">
 <bp:stepProcess rdf:resource="#BiochemicalReaction324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep369">
 <bp:stepProcess rdf:resource="#BiochemicalReaction331" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep368">
 <bp:stepProcess rdf:resource="#Catalysis94" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction330" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction109" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep367">
 <bp:stepProcess rdf:resource="#BiochemicalReaction329" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction108" />
 <bp:stepProcess rdf:resource="#Catalysis21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep366">
 <bp:stepProcess rdf:resource="#Catalysis93" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction328" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep118">
 <bp:stepProcess rdf:resource="#Pathway16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep359">
 <bp:stepProcess rdf:resource="#BiochemicalReaction321" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction334" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep371">
 <bp:stepProcess rdf:resource="#Catalysis95" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction332" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction118" />
 <bp:stepProcess rdf:resource="#Catalysis25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction338" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep375">
 <bp:stepProcess rdf:resource="#BiochemicalReaction337" />
 <bp:stepProcess rdf:resource="#Catalysis97" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep132">
 <bp:stepProcess rdf:resource="#BiochemicalReaction116" />
 <bp:stepProcess rdf:resource="#Catalysis24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction336" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep373">
 <bp:stepProcess rdf:resource="#Catalysis96" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep379">
 <bp:stepProcess rdf:resource="#Catalysis99" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction341" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep136">
 <bp:stepProcess rdf:resource="#Catalysis27" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep378">
 <bp:stepProcess rdf:resource="#BiochemicalReaction340" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction119" />
 <bp:stepProcess rdf:resource="#Catalysis26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction339" />
 <bp:stepProcess rdf:resource="#Catalysis98" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep129">
 <bp:stepProcess rdf:resource="#Catalysis23" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep128">
 <bp:stepProcess rdf:resource="#Catalysis22" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction306" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep100">
 <bp:stepProcess rdf:resource="#BiochemicalReaction88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep342">
 <bp:stepProcess rdf:resource="#BiochemicalReaction305" />
 <bp:stepProcess rdf:resource="#Catalysis86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep341">
 <bp:stepProcess rdf:resource="#BiochemicalReaction304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep340">
 <bp:stepProcess rdf:resource="#Catalysis85" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction93" />
 <bp:stepProcess rdf:resource="#Catalysis19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction310" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction92" />
 <bp:stepProcess rdf:resource="#Catalysis18" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction91" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep345">
 <bp:stepProcess rdf:resource="#BiochemicalReaction308" />
 <bp:stepProcess rdf:resource="#Catalysis87" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep102">
 <bp:stepProcess rdf:resource="#Catalysis17" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction90" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep344">
 <bp:stepProcess rdf:resource="#BiochemicalReaction307" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction302" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction301" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep337">
 <bp:stepProcess rdf:resource="#Catalysis84" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction300" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction99" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction316" />
 <bp:stepProcess rdf:resource="#Catalysis89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep110">
 <bp:stepProcess rdf:resource="#Catalysis20" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction98" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep352">
 <bp:stepProcess rdf:resource="#BiochemicalReaction315" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep116">
 <bp:stepProcess rdf:resource="#Pathway15" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction320" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep357">
 <bp:stepProcess rdf:resource="#Pathway39" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep114">
 <bp:stepProcess rdf:resource="#Pathway14" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep356">
 <bp:stepProcess rdf:resource="#BiochemicalReaction319" />
 <bp:stepProcess rdf:resource="#Catalysis91" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction318" />
 <bp:stepProcess rdf:resource="#Catalysis90" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep109">
 <bp:stepProcess rdf:resource="#BiochemicalReaction97" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep108">
 <bp:stepProcess rdf:resource="#BiochemicalReaction96" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep348">
 <bp:stepProcess rdf:resource="#Catalysis88" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction311" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction286" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep323">
 <bp:stepProcess rdf:resource="#Pathway37" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep322">
 <bp:stepProcess rdf:resource="#Pathway36" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep318">
 <bp:stepProcess rdf:resource="#BiochemicalReaction284" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep316">
 <bp:stepProcess rdf:resource="#BiochemicalReaction282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep315">
 <bp:stepProcess rdf:resource="#BiochemicalReaction281" />
 <bp:stepProcess rdf:resource="#Catalysis79" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep319">
 <bp:stepProcess rdf:resource="#BiochemicalReaction285" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep332">
 <bp:stepProcess rdf:resource="#Pathway38" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep331">
 <bp:stepProcess rdf:resource="#Catalysis83" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction295" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep330">
 <bp:stepProcess rdf:resource="#Catalysis82" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction294" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction299" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep335">
 <bp:stepProcess rdf:resource="#BiochemicalReaction298" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep333">
 <bp:stepProcess rdf:resource="#BiochemicalReaction296" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction293" />
 <bp:stepProcess rdf:resource="#Catalysis81" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep328">
 <bp:stepProcess rdf:resource="#BiochemicalReaction292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep327">
 <bp:stepProcess rdf:resource="#BiochemicalReaction291" />
 <bp:stepProcess rdf:resource="#Catalysis80" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction290" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis21">
 <bp:controlled rdf:resource="#BiochemicalReaction108" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis20">
 <bp:controlled rdf:resource="#BiochemicalReaction98" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis23">
 <bp:controlled rdf:resource="#BiochemicalReaction113" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis22">
 <bp:controlled rdf:resource="#BiochemicalReaction112" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis25">
 <bp:controlled rdf:resource="#BiochemicalReaction118" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis24">
 <bp:controlled rdf:resource="#BiochemicalReaction116" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis27">
 <bp:controlled rdf:resource="#BiochemicalReaction120" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis26">
 <bp:controlled rdf:resource="#BiochemicalReaction119" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis29">
 <bp:controlled rdf:resource="#BiochemicalReaction127" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction269" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis28">
 <bp:controlled rdf:resource="#BiochemicalReaction125" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep302">
 <bp:stepProcess rdf:resource="#Pathway35" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep301">
 <bp:stepProcess rdf:resource="#BiochemicalReaction268" />
 <bp:stepProcess rdf:resource="#Catalysis77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep300">
 <bp:stepProcess rdf:resource="#BiochemicalReaction267" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis10">
 <bp:controlled rdf:resource="#BiochemicalReaction60" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep91">
 <bp:stepProcess rdf:resource="#BiochemicalReaction80" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep90">
 <bp:stepProcess rdf:resource="#BiochemicalReaction79" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis12">
 <bp:controlled rdf:resource="#BiochemicalReaction69" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis11">
 <bp:controlled rdf:resource="#BiochemicalReaction66" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis14">
 <bp:controlled rdf:resource="#BiochemicalReaction74" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction276" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis13">
 <bp:controlled rdf:resource="#BiochemicalReaction73" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis16">
 <bp:controlled rdf:resource="#BiochemicalReaction86" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis15">
 <bp:controlled rdf:resource="#BiochemicalReaction84" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis18">
 <bp:controlled rdf:resource="#BiochemicalReaction92" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep314">
 <bp:stepProcess rdf:resource="#BiochemicalReaction280" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis17">
 <bp:controlled rdf:resource="#BiochemicalReaction90" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep312">
 <bp:stepProcess rdf:resource="#BiochemicalReaction278" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis19">
 <bp:controlled rdf:resource="#BiochemicalReaction93" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep311">
 <bp:stepProcess rdf:resource="#BiochemicalReaction277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep306">
 <bp:stepProcess rdf:resource="#BiochemicalReaction272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep305">
 <bp:stepProcess rdf:resource="#BiochemicalReaction271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction270" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep308">
 <bp:stepProcess rdf:resource="#Catalysis78" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep95">
 <bp:stepProcess rdf:resource="#BiochemicalReaction84" />
 <bp:stepProcess rdf:resource="#Catalysis15" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep94">
 <bp:stepProcess rdf:resource="#BiochemicalReaction83" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep93">
 <bp:stepProcess rdf:resource="#BiochemicalReaction82" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep92">
 <bp:stepProcess rdf:resource="#BiochemicalReaction81" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep99">
 <bp:stepProcess rdf:resource="#BiochemicalReaction87" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep98">
 <bp:stepProcess rdf:resource="#BiochemicalReaction86" />
 <bp:stepProcess rdf:resource="#Catalysis16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep97">
 <bp:stepProcess rdf:resource="#Pathway13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep96">
 <bp:stepProcess rdf:resource="#BiochemicalReaction85" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis61">
 <bp:controlled rdf:resource="#BiochemicalReaction195" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis60">
 <bp:controlled rdf:resource="#BiochemicalReaction193" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis63">
 <bp:controlled rdf:resource="#BiochemicalReaction198" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis62">
 <bp:controlled rdf:resource="#BiochemicalReaction196" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis65">
 <bp:controlled rdf:resource="#BiochemicalReaction200" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis64">
 <bp:controlled rdf:resource="#BiochemicalReaction199" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis67">
 <bp:controlled rdf:resource="#BiochemicalReaction203" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis66">
 <bp:controlled rdf:resource="#BiochemicalReaction202" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis69">
 <bp:controlled rdf:resource="#BiochemicalReaction205" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis68">
 <bp:controlled rdf:resource="#BiochemicalReaction204" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep69">
 <bp:stepProcess rdf:resource="#BiochemicalReaction62" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep68">
 <bp:stepProcess rdf:resource="#BiochemicalReaction61" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep67">
 <bp:stepProcess rdf:resource="#Catalysis10" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep62">
 <bp:stepProcess rdf:resource="#BiochemicalReaction56" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep61">
 <bp:stepProcess rdf:resource="#BiochemicalReaction55" />
 <bp:stepProcess rdf:resource="#Catalysis7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep60">
 <bp:stepProcess rdf:resource="#BiochemicalReaction54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep66">
 <bp:stepProcess rdf:resource="#BiochemicalReaction59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep65">
 <bp:stepProcess rdf:resource="#BiochemicalReaction58" />
 <bp:stepProcess rdf:resource="#Catalysis9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep64">
 <bp:stepProcess rdf:resource="#BiochemicalReaction57" />
 <bp:stepProcess rdf:resource="#Catalysis8" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis70">
 <bp:controlled rdf:resource="#BiochemicalReaction206" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep63">
 <bp:stepProcess rdf:resource="#Pathway8" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis50">
 <bp:controlled rdf:resource="#BiochemicalReaction170" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis52">
 <bp:controlled rdf:resource="#BiochemicalReaction172" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis51">
 <bp:controlled rdf:resource="#BiochemicalReaction171" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis54">
 <bp:controlled rdf:resource="#BiochemicalReaction174" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis53">
 <bp:controlled rdf:resource="#BiochemicalReaction173" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis56">
 <bp:controlled rdf:resource="#BiochemicalReaction177" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis55">
 <bp:controlled rdf:resource="#BiochemicalReaction176" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis58">
 <bp:controlled rdf:resource="#BiochemicalReaction189" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis57">
 <bp:controlled rdf:resource="#BiochemicalReaction180" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis59">
 <bp:controlled rdf:resource="#BiochemicalReaction192" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep59">
 <bp:stepProcess rdf:resource="#BiochemicalReaction53" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep58">
 <bp:stepProcess rdf:resource="#Pathway7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep57">
 <bp:stepProcess rdf:resource="#Pathway6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep56">
 <bp:stepProcess rdf:resource="#BiochemicalReaction52" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep51">
 <bp:stepProcess rdf:resource="#BiochemicalReaction47" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep50">
 <bp:stepProcess rdf:resource="#BiochemicalReaction46" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep55">
 <bp:stepProcess rdf:resource="#BiochemicalReaction51" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep54">
 <bp:stepProcess rdf:resource="#BiochemicalReaction50" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep53">
 <bp:stepProcess rdf:resource="#BiochemicalReaction49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep52">
 <bp:stepProcess rdf:resource="#BiochemicalReaction48" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis41">
 <bp:controlled rdf:resource="#BiochemicalReaction154" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis40">
 <bp:controlled rdf:resource="#BiochemicalReaction150" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep80">
 <bp:stepProcess rdf:resource="#Pathway10" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis43">
 <bp:controlled rdf:resource="#BiochemicalReaction159" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis42">
 <bp:controlled rdf:resource="#BiochemicalReaction158" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis45">
 <bp:controlled rdf:resource="#BiochemicalReaction161" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis44">
 <bp:controlled rdf:resource="#BiochemicalReaction160" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis47">
 <bp:controlled rdf:resource="#BiochemicalReaction167" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis46">
 <bp:controlled rdf:resource="#BiochemicalReaction163" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis49">
 <bp:controlled rdf:resource="#BiochemicalReaction169" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis48">
 <bp:controlled rdf:resource="#BiochemicalReaction168" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep89">
 <bp:stepProcess rdf:resource="#BiochemicalReaction78" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep84">
 <bp:stepProcess rdf:resource="#BiochemicalReaction74" />
 <bp:stepProcess rdf:resource="#Catalysis14" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep83">
 <bp:stepProcess rdf:resource="#BiochemicalReaction73" />
 <bp:stepProcess rdf:resource="#Catalysis13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep82">
 <bp:stepProcess rdf:resource="#Pathway11" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep81">
 <bp:stepProcess rdf:resource="#BiochemicalReaction72" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep88">
 <bp:stepProcess rdf:resource="#BiochemicalReaction77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep87">
 <bp:stepProcess rdf:resource="#BiochemicalReaction76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep86">
 <bp:stepProcess rdf:resource="#BiochemicalReaction75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep85">
 <bp:stepProcess rdf:resource="#Pathway12" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis30">
 <bp:controlled rdf:resource="#BiochemicalReaction130" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis32">
 <bp:controlled rdf:resource="#BiochemicalReaction134" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis31">
 <bp:controlled rdf:resource="#BiochemicalReaction133" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis34">
 <bp:controlled rdf:resource="#BiochemicalReaction139" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis33">
 <bp:controlled rdf:resource="#BiochemicalReaction136" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis36">
 <bp:controlled rdf:resource="#BiochemicalReaction143" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis35">
 <bp:controlled rdf:resource="#BiochemicalReaction140" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis38">
 <bp:controlled rdf:resource="#BiochemicalReaction146" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis37">
 <bp:controlled rdf:resource="#BiochemicalReaction144" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis39">
 <bp:controlled rdf:resource="#BiochemicalReaction149" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep79">
 <bp:stepProcess rdf:resource="#BiochemicalReaction71" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep78">
 <bp:stepProcess rdf:resource="#BiochemicalReaction70" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep73">
 <bp:stepProcess rdf:resource="#BiochemicalReaction65" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep72">
 <bp:stepProcess rdf:resource="#BiochemicalReaction64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep71">
 <bp:stepProcess rdf:resource="#Pathway9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep70">
 <bp:stepProcess rdf:resource="#BiochemicalReaction63" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep77">
 <bp:stepProcess rdf:resource="#BiochemicalReaction69" />
 <bp:stepProcess rdf:resource="#Catalysis12" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep76">
 <bp:stepProcess rdf:resource="#BiochemicalReaction68" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep75">
 <bp:stepProcess rdf:resource="#BiochemicalReaction67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep74">
 <bp:stepProcess rdf:resource="#BiochemicalReaction66" />
 <bp:stepProcess rdf:resource="#Catalysis11" />
</bp:PathwayStep>
</rdf:RDF>